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ABSTRACT 
Clostridium difficile spore germination is critical for the transmission of disease. 
C. difficile spores germinate in response to cholic acid derivatives, such as taurocholate 
(TA), and amino acids, such as glycine or alanine. Many endospore-forming bacteria 
embed alanine racemases into their spore coats and these enzymes are thought to convert 
the L-alanine germinant into D-alanine, a spore germination inhibitor. C. difficile packages 
the Alr2 alanine racemase into the spore. Here, I describe my findings that alr2 mutant 
spores more readily germinate in response to L-alanine as a co-germinant. Surprisingly, 
D-alanine also functioned as a co-germinant. Finally, I demonstrated that L- and D-serine 
are also co-germinants for C. difficile spores and C. difficile Alr2 can accommodate both 
alanine and serine as substrates. 
During the analysis on Alr2, I found that D-alanine can function as a co-germinant 
for C. difficile spores at 37 ºC but not at 25 ºC. Because most germination assays are 
conducted at room temperature, I tested the ability of other amino acids to act as co-
germinants with TA at 37 ºC and found that many amino acids previously categorized as 
non-co-germinants are actually co-germinants at 37 ºC. 
Even though C. difficile spore germination is known to require an amino acid co-
germinant, the amino acid spore germinant receptor was unknown. In search of the amino 
acid germinant receptor, I used EMS mutagenesis as a strategy to generate mutants with 
altered requirements for the amino acid co-germinant, similar to the strategy used 
previously to identify the bile acid receptor, CspC. Surprisingly, I identified strains that do 
not require amino acids as co-germinants, and the mutant spores germinated in response 
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to TA alone. Upon sequencing these mutants, I identified non-isogenic mutations in yabG. 
For C. difficile, the YabG protease is critical for the processing of CspBA to CspB and 
CspA and preproSleC to proSleC during spore formation. A defined yabG mutant 
exacerbated the EMS mutant phenotype. Moreover, I found that various mutations in cspA 
caused spores to germinate in the presence of TA alone without the requirement of an 
amino acid. Thus, my study provides evidence that apart from regulating the CspC levels 
in the spore, CspA is important for recognition of amino acids as co-germinants during C. 
difficile spore germination and that two pseudoproteases (CspC and CspA) function as the 
C. difficile germinant receptors. 
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NOMENCLATURE 
 
ADP adenosine di-phosphate 
AGFK L-asparagine, glucose, fructose and K+ ions 
ANOVA Analysis of variance 
ATP adenosine tri-phosphate 
AU arbitrary units 
BHIS Brain Heart Infusion, supplemented with 5 g /L Yeast extract 
BHIS-TA BHIS supplemented with taurocholic acid 
CaDPA calcium dipicolinic acid 
CDC Centers for Disease Control and Prevention 
CDCA Chenodeoxycholic acid 
CDI Clostridium difficile Infection 
CDMM C. difficile minimal media 
CDT C. difficile transferase 
CPD cysteine protease domain 
CROPs combined repeated oligopeptides 
DNA Deoxyribonucleic acid 
DPA Dipicolinic acid 
EC50 concentration that achieves half-maximum germination rate 
EMS   Ethyl methanesulfonate 
FDA   Food and Drug administration 
FDAA   1-fluoro-2-4-dinitrophenyl-5-L-alanine amide 
 viii 
 
 
FMT   fecal microbiota transplantation 
FOA 5-fluoroorotic acid 
GTD glucosyltransferase domain 
GTP guanosine triphosphate  
HEPES 2-[4-(2-hydroxyethyl) piperazin-1-yl] ethanesulfonic acid 
HPLC High Performance Liquid Chromatography 
IM inner membrane 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
ITC isothermal titration calorimetry 
Ki apparent inhibitory constant 
Km apparent rate of germination 
LB Luria-Bertani medium 
MAL muramic-δ-lactam 
NAD+ Nicotinamide adenine dinucleotide (oxidized) 
NADH Nicotinamide adenine dinucleotide (reduced) 
NAG N-acetylgycosamine 
NAM N-acetylmuramic acid 
OD600 optical density measured at 600 nm 
PaLoc pathogenicity locus 
PCR polymerase chain reaction 
PLP pyridoxal 5’ phosphate 
PMSF phenyl methane sulfonyl fluoride 
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PMT photomultiplier tube 
PVDF Polyvinylidene difluoride 
RBD receptor binding domain 
RNA ribonucleic acid 
SASPs small acid soluble proteins 
SCLEs spore cortex lytic enzymes 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SNPs single-nucleotide polymorphism  
TA taurocholic acid 
TBS Tris-buffered saline 
TBST TBS supplemented with 1% (vol / vol) Tween 20 
TcdA Clostridium difficile Toxin A 
TcdB Clostridium difficile Toxin B 
TCEP Tris(2-carboxyethyl) phosphine 
TY Tryptone yeast medium 
UV Ultraviolet light 
WT wildtype 
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CHAPTER I 
INTRODUCTION TO Clostridium difficile SPORES 
1.1 Epidemiology 
Clostridium difficile, also known as Clostridioides difficile (1), is a Gram-positive, 
endospore forming bacterium and is a leading cause of antibiotic associated diarrhea and 
healthcare-associated infections (2). Although C. difficile was first isolated from a stool 
of a healthy infant in 1935, C. difficile was only linked with human disease in 1978 (3, 4). 
Each year, nearly half a million C. difficile infections (CDI) are present in the US and lead 
to approximately 30,000 deaths (2, 5). The financial burden for the treatment of CDI in 
the healthcare system exceeds more than $4 billion per year (6). Due to its natural and 
developing antibiotic resistance, the CDC (Centers for Disease Control and Prevention) 
has listed C. difficile as an urgent threat in the US healthcare system (2, 5, 7). 
 The current treatment options for CDI are broad-spectrum antibiotics, i.e., 
vancomycin, or fidaxomicin (8). However, the use of broad-spectrum antibiotics has been 
discouraged due to their continued disruption of the colonic microbiota, which plays a key 
role in the resistance to colonization by C. difficile (9). Due to this continued disruption, a 
patient will frequently experience recurring disease. Treatments involving the restoration 
of a healthy microbiome through biotherapeutic strategies such as fecal microbiota 
transplantation (FMT), have become popular in recent years due to the ~ 90% cure rate 
(10, 11). 
  Another biotherapeutic strategy to treat CDI is the use of monoclonal antibodies 
directed against the C. difficile toxins. This strategy protects against recurrence by 
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mediating early reconstruction of gut microbiota and the cessation of CDI symptoms (12). 
Interestingly, only Bezlotoxumab (directed against TcdB) protects against CDI (13). In 
fact, Bezlotoxumab is the first FDA-approved monoclonal antibody shown to have 
effectiveness in prevention of recurrent CDI. Although, the use of Bezlotoxumab as a 
treatment is a very compelling therapy against CDI, there are still risks associated with 
this therapy (13, 14) due to the limited data on the effectiveness against the prevention of 
CDI.  
Another treatment strategy being studied is the use of competitive inhibition with 
non-toxigenic C. difficile strains. Development of vaccines to treat against CDI is another 
emerging therapeutic treatment (15). Wang et al., developed an oral vaccine, mTcd138, 
which contains only some domains of the toxin and can target both C. difficile toxins and 
colonization factors. They found that in both mice and hamsters that oral immunization 
with non-toxigenic strains protected fully against the hyper-virulent strain UK6 (ribotype 
027) (15). However, a recent Phase III clinical trial that tested the effectiveness of a 
potential C. difficile vaccine failed (14). Since this is very recently published data more 
study is required for it to be considered as a future CDI treatment. 
1.2 Toxin secretions 
Upon colonization, C. difficile vegetative cells secrete two toxins, TcdA (an 
enterotoxin) and TcdB (a cytotoxin) (16). The genes encoding these toxins, tcdA and tcdB, 
are located within the pathogenicity locus (PaLoc) (17-19). In addition to tcdA and tcdB, 
the PaLoc also encodes three other genes, i) tcdR, encoding an alternative RNA 
polymerase sigma factor that is responsible for the expression of tcdA and tcdB ii) tcdE, 
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encoding a holin-like protein necessary for the extracellular release of both toxins and iii) 
tcdC, encoding an anti-sigma factor that negatively regulates the expression of toxins (16, 
20, 21). TcdA and TcdB, share a multi-modular domain structure described as the ABCD 
model (A: biological activity; B: binding; C: cutting; D: delivery). Region A, located at 
the N-terminus, contains a glucosyltransferase domain (GTD) that acts on the small 
GTPases involved in regulation of the cytoskeleton. Region B, located at the C-terminus, 
consists of combined repeated oligopeptides (CROPs) that form the receptor binding 
domain (RBD) and help in the initial interaction with the host cell. Region C is the cysteine 
protease domain (CPD) that promotes the auto-catalytic cleavage of the GTD from the 
larger protein. Region D, located in the middle of the protein, is the delivery domain that 
is involved in the translocation of the toxin into the cytosol from the acidified endosome 
(16, 22). 
Environmental signals such as nutrient limitation, change in temperature or change 
in the redox potential regulates the expression of TcdA and TcdB toxins. Once toxins are 
produced by the vegetative cell, toxins are delivered into the host cell cytosol by binding 
of RBD to the host cell surface receptor. The two toxins have different receptors in the 
host. For example, sucrase-isomaltase and the glycoprotein 96 (gp96) produced by the 
host colonocyte apical membrane recognize TcdA RBD (23) while the chondroitin sulfate 
proteoglycan 4 (CSPG4), the poliovirus receptor-like 3 (PVRL3) (24), and frizzled 
proteins (FZD1, 2 and 7) (25) have been identified as TcdB receptors. When the RBD 
domain bind to their specific receptors, the toxins are internalized through receptor-
mediated endocytosis (26). Toxin once internalized, can acidify endosomes leading to 
4 
pore formation. The acidification of the endosome alters the structure of the toxin through 
a pH-induced conformational change that helps in the translocation of the toxin into the 
host cytosol. As the toxins enter the host cytosol, inositol hexakisphosphate-dependent 
autocatalytic cleavage releases the GTD of the toxin (27, 28). The GTD then inactivates 
the Rho-family of small GTPases leading to loss of barrier function and inflammation of 
the colonic epithelium causing symptoms ranging from mild to severe diarrhea to other 
possibly fatal conditions such as pseudomembranous colitis and toxic megacolon (20, 29, 
30). 
Some C. difficile strains produce a binary toxin, C. difficile transferase (CDT). 
CDT belongs to the family of binary ADP-ribosylating toxins and consists of two separate 
toxin components: CDTa - an enzymatic component and CDTb - a binding component 
(22). CDTa is the biologically active ADP-ribosyltransferase processing component and 
is required for actin modification. The CDTb component binds to host cells and is required 
for the translocation of CDTa into the host cytosol (22). Several studies indicate that C. 
difficile strains that produce binary toxin, in addition to TcdA and TcdB, are associated 
with high mortality rates which make CDI even more challenging for treatment. 
1.3 Ultrastructure of C. difficile spore 
Apart from toxins that cause CDI, C. difficile vegetative cells also produce spores, 
which are critical for the transmission between hosts because of their resistance to 
environmental factors such as heat, UV, chemicals and, importantly, oxygen (31, 32). The 
C. difficile spore ultrastructure is similar to other endospore-forming bacteria. Endospores 
are composed of several layers. Located at the center of the spore, the core contains the 
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DNA, RNA, ribosomal proteins and enzymes that are essential for eventual vegetative 
growth (15, 33-35). The DNA in the core is protected from UV damage by small acid 
soluble proteins (SASPs) (36). The core is dehydrated and much of the water in the core 
is replaced by pyridine-2, 6-dicarboxylic acid (dipicolinic acid; DPA), chelated with 
calcium (CaDPA), and provides heat resistance to the spores (33, 34). The core is 
surrounded by an inner membrane (IM) composed of phospholipids with minimal 
permeability to small molecules, including water. The IM is surrounded by a thin germ-
cell-wall layer that becomes the cell wall of the vegetative cell upon outgrowth of the 
germinated spore. The germ cell wall is composed of layers of peptidoglycan, which is 
formed by linear chains of two alternating amino sugars, N-acetylglucosamine (NAG) and 
N-acetylmuramic acid (NAM) connected by peptide crosslinks (35, 37). The germ-cell 
wall is surrounded by a thick layer of specialized peptidoglycan layer (the cortex). In B. 
subtilis, the cortex has three different modifications that makes the cortex layer different 
than the germ-cell wall: i) muramic-δ-lactam (MAL) residues replace 50% of the muramic 
acid residues in cortex peptidoglycan; (ii) some of the NAM residues are substituted with 
short peptides lowering the crosslinking in the cortex; and (iii) approximately one fourth 
of the NAM residues have a single L-alanine residue (35, 37-40). This unique property of 
the cortex is critical for maintaining the partially dehydrated state of the core as it prevents 
the core expansion. During germination, which will be discussed below, cortex degrading 
enzymes recognize the unique modifications so that the germ cell wall is not degraded 
(41). Surrounding the cortex is the outer spore membrane. Although present as a spore 
layer, the exact role of the outer spore membrane is not yet understood. The outer spore 
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membrane is surrounded by several layers of coat proteins. Nearly 30% percent of total 
spore proteins are present in the coat layer (42). The spore coat provides a barrier against 
lytic enzymes and toxic chemicals and thus, is important for the protection of cortex layer, 
which is susceptible to peptidoglycan-degrading enzymes such as lysozyme (32). The coat 
layers also have an important function in the interaction of the spores with germination- 
inducing molecules (germinants). Some endospore-forming bacteria produce endospores 
with an additional layer known as the exosporium, which consists of a paracrystalline 
basal layer and an external hair-like structure (35, 43). Apart from providing resistance to 
chemical and enzymatic reactions, the exosporium also provides a hydrophobic surface 
that enhances the adhesion properties of the spore and may contribute to the pathogenesis 
of some bacteria (35). 
1.4 Sporulation 
 The signals that trigger the C. difficile sporulation pathway are not yet identified. 
However, many environmental factors, such as nutrient deprivation and quorum-sensing 
lead to the activation of the sporulation pathway (44). Like other spore-forming organisms 
(e.g., B. subtilis), sporulation in C. difficile also contains four morphogenic stages (Figure 
1): (i) generation of a smaller compartment (forespore) and larger compartment (mother 
cell) through an asymmetric division event; (ii) engulfment of the forespore by the mother 
cell in a phagocytic-like event; (iii) assembly of the cortex and the coat layer; and (iv) 
release of the mature spore from the mother cell (34). 
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Figure 1. Morphogenic stages during sporulation (reprinted from (34) 
During sporulation, a cell divides asymmetrically generating a larger mother compartment 
and a smaller forespore compartment. After DNA segregation, the mother cell engulfs the 
forespore followed by formation of spore cortex, inner and outer coat layers. Once spore 
formation is complete, the mother cell lyses and the mature spore is released.  
(MC, mother cell compartment; FS, forespore compartment; MS, mature spore) 
 
 
In most endospore-forming bacteria, sporulation is activated by phosphorylation 
of the master transcriptional regulator, Spo0A (45), by several orphan histidine kinases 
(46). Spo0A expression is under the control of Sigma H (σH), an alternative sigma factor 
that stimulates the production of early sporulation proteins during the post-exponential 
growth phase. As shown in Figure 2, Spo0A regulates sporulation-specific RNA 
polymerase sigma factors σE and σF (34). These σ factors activate compartment-specific 
transcriptional regulation during sporulation. In B. subtilis, activation of the sigma factor 
occurs in a ‘crisscross’ pattern between mother cell and forespore. As in B. subtilis, C. 
difficile, σE and σK are mother cell-specific, and σF and σG are specific to the developing 
forespore (47). 
In both B. subtilis and C. difficile, activation of σF results in the expression of 
SpoIIR, which interacts with the membrane-bound protease SpoIIGA. SpoIIGA processes 
pro-σE to the active σE form in the mother cell. The activation of σE leads to the expression 
of genes whose products are required for the mother cell to engulf the forespore. In the 
forespore, σF regulates the expression of SpoIIQ, and, in the mother cell, σE leads to 
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expression of SpoIIIA-H (34). These proteins are required to form a channel between the 
inner and outer forespore membranes. σE controls expression of SpoIIID, which positively 
regulates the expression of sigK in the mother cell (47). SigK regulates the late stage of 
sporulation where many genes encoding the spore coat and spore exosporium proteins are 
synthesized.  
 
 
 
Figure 2. Comparison of activation of sigma factor in Bacillus subtilis and 
Clostridium difficile. (reprinted from (34) 
Models of global regulatory pathway of the four-major sporulation specific factors in B. 
subtilis and C. difficile.  
 
 
After the completion of engulfment, two types of peptidoglycans are layered 
between the inner and outer membranes that surround the prespore. A thin layer of germ 
cell peptidoglycan is layered on the surface of the inner spore membrane. The germ cell 
wall serves as the wall of newly formed vegetative cell after spore germination. The cortex 
layer is assembled on the inner surface of the outer prespore membrane and is distinct in 
chemical composition compared to germ cell wall peptidoglycan. During spore cortex 
  
9 
 
 
synthesis, the protein coat is deposited around the outer surface of the outer membrane, 
subsequently the exosporium is assembled. 
The composition of the coat in C. difficile differs from B. subtilis. Out of 70 B. 
subtilis spore coat proteins, only 18 orthologues are found in C. difficile (48). In B. subtilis, 
coat assembly occurs when mother cell encloses the forespore with a series of 
proteinaceous shells. These shells include the basement layer, the inner coat, the outer 
coat, and the crust layers. The formation of the first three coat layers involves the SpoVM, 
SpoIVA, SpoVID, SafA, and CotE proteins. Interestingly, C. difficile only encodes 
orthologues of SpoIVA, SpoVM and CotE (49-51). SpoIVA is essential for coat 
biogenesis in both B. subtilis and C. difficile. In C. difficile, recently identified SipL, is 
hypothesized to function like B. subtilis SpoIVD. SipL binds to SpoIVA, and the 
SipL/SpoIVA complex is required as a foundation for the spore coat assembly (51). In 
addition, B. subtilis SpoIVA recruits another morphogenetic protein, SafA, while CotE is 
recruited by both SpoIVA and SpoVID (34). C. difficile encodes only a CotE orthologue. 
Whether or not other proteins are recruited by SpoIVA and SipL is unknown. 
In both Bacillus anthracis and C. difficile spores, the exosporium surrounds the 
coat layers. Similar to what is observed in B. anthracis spores, the C. difficile exosporium 
also lacks a clear gap/inner coat space. C. difficile strain 630 encodes three paralogs of the 
B. anthracis collagen-like glycoprotein BclA (bclA1 [CD0332], bclA2 [CD3230], and 
bclA3 [CD3349]) (43, 52). These proteins contain three domains: (i) an N-terminal domain 
of variable size; (ii) a collagen-like domain; (iii) and a C-terminal domain (53). However, 
the particular role of the other BclA paralogs in C. difficile is not clear. Recently, Barra-
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Carrasco et al. found that the cysteine-rich exosporium protein CdeC (CD1067) is unique 
to C. difficile and is essential for the proper assembly of the exosporium. Mutations in 
cdeC dramatically decrease the abundance of the exosporium in the spores resulting in 
defects in coat and exosporium assembly (54). 
1.5 C. difficile spore germination 
C. diffiicle can only become pathogenic when it transforms from a spore to a 
vegetative cell, through a process known as germination. Upon sensing various species-
specific germination cues, dormant spores awake and become metabolically active. Spore 
germination has been studied extensively in B. subtilis. In B. subtilis, various agents (e.g. 
amino acids, sugars, CaDPA, dodecyl amine or peptidoglycan fragments) trigger B. 
subtilis spore germination (55, 56). However, in nature, germination of B. subtilis spores 
by nutrient is most likely. B. subtilis spores germinate in response to L-alanine or to the 
combination of L-asparagine, D-glucose, D-fructose and potassium ions (AGFK), which 
bind to spore-specific protein complexes, germinant receptors that are located in the IM. 
The B. subtilis GerA germinant receptor (a combination of the GerAA, GerAB and GerAC 
proteins) recognizes L-alanine as a germinant (57). B. subtilis spores also germinate in 
response to AGFK via cooperative action between GerB and GerK (56, 58). Only the L-
form of amino acids can trigger germination of B. subtilis spores. In fact, some D-amino 
acids inhibit the germination of B. subtilis spores (59). 
In contrast to B. subtilis, C. difficile does not encode orthologues of the Ger-type 
germinant receptors. Germination by C. difficile spores is triggered in response to certain 
bile acids [cholic acid-derivatives, such as taurocholate (TA)] in combination with certain 
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amino acids (e.g. glycine or L-alanine) (60). The bile acid germinant receptor, CspC was 
identified in a random mutagenesis screen (61). A single point mutation in cspC resulted 
in loss of recognition of TA as a germinant. In addition, C. difficile spore germination was 
inhibited by chenodeoxycholic derivatives (CDCA). Similarly, a single substitution in 
CspC (G457R) resulted in spores no longer being inhibited by CDCA. Instead, these 
mutant spores recognized CDCA as a germinant (61). These results suggested that CspC 
is the bile acid germinant receptor and is important for recognition of both TA (an 
activator) or CDCA (an inhibitor) during germination of C. difficile spore (61-63). 
The Csp locus was originally studied in Clostridium perfringens (64). C. 
perfringens encodes three Csp proteases, CspB, CspA, and CspC. Each are predicted to 
cleave the inhibitory pro-peptide from proSleC, a spore cortex hydrolase that degrades the 
cortex peptidoglycan, thereby activating the protein. In C. perfringens spores, although 
CspB, CspA and CspC are present, germination occurs similar to that of B. subtilis due to 
presence of orthologues of GerA, GerB and GerK (64-66). 
In C. difficile, CspB and CspA are encoded by one ORF upstream of cspC, and the 
resulting protein (CspBA) is post-translationally processed into CspB and CspA and then 
further processed by the sporulation specific protease, YabG. To date, YabG has only been 
studied in B. subtilis where YabG processes several coat related proteins (67, 68). Clearly, 
the proteins targeted by the YabG protease in B. subtilis and C. difficile are different (67, 
69). In C. difficile, apart from the processing of the CspBA interdomain processing, YabG 
is also responsible for processing preproSleC into the proSleC form found in the spore. 
The yabG mutant spores accumulate mostly preproSleC and CspBA (69). 
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In our original working model for spore germination (Figure 3B), we hypothesized 
that proSleC, CspB, CspC and CspA are in a complex where proSleC is held in an inactive 
state by its propeptide. CspC, the bile acid receptor, is activated by TA, which leads to the 
activation of the CspB protein. The CspB serine protease cleaves proSleC into its active 
form. Activated SleC then degrades the cortex layer and results in the core releasing 
CaDPA, in exchange for water, through the SpoVA mechanosensing channel (70). At the 
time we generated this model, the role of CspA in spore germination was unknown. 
However, deletion of CspA greatly affects the incorporation of CspC into the spore, 
thereby influencing germination due to lack of the bile acid germinant receptor (69). 
During C. difficile spore germination amino acids are also required as a co-germinant 
along with TA. However, it is not understood where and how amino acids are playing a 
role during germination. 
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Figure 3. Working model for C. difficile spore germination 
A) Overall architecture of a dormant spore. The core contains CaDPA, DNA etc. and is 
surrounded by inner membrane, germ cell wall, cortex, coat layers and an exosporium. B) 
Prior to publication of this thesis, our working model for C. difficile spore germination 
hypothesized that proSleC is forms a complex with CspB, CspC and CspA in the cortex. 
CspC, the bile acid germinant receptor, is activated in response to cholic acid-derivatives 
and inhibited by chenodeoxycholic acid-derivatives. Activation of CspC leads to 
activation of the CspB protease, which cleaves pro-SleC to its active form. Activated SleC 
hydrolyzes the cortex which results in the release of CaDPA from the core. An amino acid, 
such as glycine, is also required in the germination process, though was not clear where 
and how it binds. 
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1.6 Proteins indirectly involved during germination by C. difficile spores 
Recent studies on C. difficile spore germination have identified several other 
proteins that are involved in spore germination. GerS is the second most highly expressed 
protein during sporulation and also plays a role in germination, encodes a lipoprotein; a 
gerS mutant germinates poorly (71). Even though SleC is activated in gerS mutants in 
response to germinants, these mutants failed to degrade the cortex and as a result, do not 
release DPA. Originally, GerS was hypothesized to be a part of the germination complex, 
potentially by anchoring proSleC to the inner leaflet of the outer spore membrane (71). 
However, in subsequent work, GerS, along with CwlD (a muramoyl-L-Alanine amidase) 
(i.e., MAL) and PdaA (a polysaccharide deacetylase) were shown to be required for the 
cortex-specific modifications of peptidoglycan. In mutants where these modifications are 
hindered, SleC fails to degrade the cortex (72). 
A separate study identified GerG as another C. difficile germination protein. GerG 
which encodes a protein with gel forming properties (73). A deletion of gerG results in a 
reduced response to bile acid germinants. GerG is required for the incorporation of 
important germination proteins such as CspB, CspA and CspC into spores. While CspA 
also controls the incorporation of CspC, it was shown that GerG acts upstream of CspA 
and is responsible for incorporation of all three Csp proteins in the spore (73). 
1.7 Importance of amino acid co-germinants during C. difficile spore germination 
Although bile acids are important, germination of C. difficile spores cannot occur 
without an amino acid co-germinant and, prior to publication of this thesis, the amino acid 
germinant receptor was still unknown. Glycine is the most efficient co-germinant but other 
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L-forms of amino acids, such as L-alanine or L-cysteine, can also efficiently trigger C. 
difficile spore germination (74). Unlike B. subtilis, C. difficile spore germination is not 
inhibited by the D-forms of amino acids. However, in a previous study, D-amino acids did 
not activate C. difficile spore germination (74). In other spore-forming bacteria, amino 
acid racemases play important roles in spore germination (as well as during a vegetative 
growth). In B. subtilis, the spore specific-alanine racemase converts L-alanine to D-alanine 
to suppress spore germination in response to L-alanine (75). This is thought to prevent 
germination of the developing spore within the mother cell where L-alanine is present. In 
C. difficile, the alr2 alanine racemase is encoded downstream of gerS and is very highly 
expressed during sporulation (71). However the inactivation of C. difficile alr2 had 
minimal impact on C. difficile spore germination, when analyzed in rich medium (71). 
Since all amino acids are present in rich medium, under this condition the effect of Alr2 
during C. difficile spore germination might be masked. 
 Prior work on amino acid co-germinants in C. difficile spore germination has 
suggested that C. difficile spores contain an amino acid germinant receptor that recognizes 
multiple amino acids as co-germinants(74). Several amino acid analogs were tested to 
understand is the amino acids interact with a putative receptor by analyzing the kinetics 
of spore germination. The study showed that the C. difficile germination machinery 
recognizes different amino acid side chains. In addition, the putative glycine receptor 
requires both a free carboxylate and a free amino group to recognize glycine, however, the 
binding site is flexible enough to accommodate longer separations between the two 
functional groups (74). Moreover, D-amino acids did not contribute to germination of C. 
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difficile, suggesting that putative germinant receptor is specific to L-form of amino acids. 
Among various L amino acids tested, apart from L-alanine, only L-cysteine, L-
phenylalanine and L-arginine were able to function as co-germinants. Another study 
showed that L-histidine could also contribute to germination of C. difficile along with TA 
(76). Also, because none of the amino acid analogs was able to compete with glycine to 
inhibit C. difficile spore germination, the study suggested that the functional groups in the 
amino acid moieties are needed for both binding and activation of the putative amino acid 
germination receptor (74). 
1.8 Role of calcium during germination 
 Recently, calcium was identified as an important contributor to spore 
germination, though its precise role remains unclear (77). Calcium may function as a bona 
fide spore co-germinant, a co-factor for a process essential for spore germination and/or 
as an enhancer for amino acids. CaDPA also induce germination in Bacillus subtilis spores 
(77). Spores of several Bacillus species contain two cortex lytic enzymes, SleB and CwlJ 
(78). While SleB is activated when a nutrient germinant bind to its respective receptor, 
CwlJ is activated in the presence of endogenous or exogeneous CaDPA (56, 79). C. 
difficile, however does not encode orthologues of CwlJ, and only encodes SleC, 
suggesting that germination by endogenous CaDPA and TA in C. difficile does not follow 
the same pathway was in B. subtilis. Prior work has shown that the cortex degrading 
enzyme SleM of C. perfringens require divalent cations (including Ca2+) for activity (64). 
Thus in C. difficile, Ca2+ may be required for the activity of the cortex degrading enzyme 
SleC. 
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1.9 Environmental factors affecting germination 
 The most obvious environmental factor that influences spore germination are the 
concentration of the germinants. Optimum concentrations of both amino acid and bile 
acids are required for the germination of the C. difficile spores. The EC50 (the 
concentration that achieves half-maximum germination rate) of TA is approximately 2 
mM. and the EC50 of glycine is approximately 1 mM (80). Interestingly, the postprandial 
bile acid concentration in the human distal ileum averages 2 mM, whereas postprandial 
bile acid concentration in the proximal ileum averages 10 mM (81, 82). Similarly, with 
amino acids being a large part of human diet, they are present at high in the gut. 
Another important factor influencing germination is pH. The optimum pH required 
for the germination of C. difficile spores is between 6.3 to 7.5. Normally in vitro 
germination is performed at pH 7.5. Though alkaline pH (8.2-8.4) marginally reduced the 
germination of C. difficile spores, an acidic pH significantly reduced germination (63). In 
vivo, the stomach pH ranges between 1.5 – 2.0 (63), suggesting that C. difficile spores are 
unable to germinate under these conditions. The colonic environment can be acidic or 
neutral depending on the region. For example, in the small intestine, the pH ranges 
between 6.0 – 7.5, and, similarly in the large intestine the pH ranges between 5.8 – 7.0, 
which is suitable pH for the germination of the C. difficile spores (83). 
Temperature also plays a significant role during germination. The rate of 
germination significantly increases when the temperature is increased from 20 °C to 37 
°C, however there was no effect on the extent of germination, suggesting that at both 
temperatures, spores can germinate completely but at different rates (63). 
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In other spore-forming organisms, the medium in which spores were prepared 
influences the rate of germination by increasing in the number of germinant receptors (84, 
85). In C. difficile, it has only been reported that preparation of spores in different nutrient 
media increases the number of spores compared to BHIS medium (51). However, it has 
not been shown whether there is an effect of different media on germination, or if different 
media cause a change in the germination specific proteins of C. difficile spores. 
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CHAPTER II 
A Clostridium difficile ALANINE RACEMASE AFFECTS SPORE 
GERMINATION AND ACCOMMODATES SERINE AS A SUBSTRATE* 
 
 In Chapter II, we identified the role of alanine racemase (Alr2) during C. difficile 
spore germination. We also looked for other substrate of Alr2 other than alanine. The ITC 
work on this chapter was done in collaboration with Dr. Steve W. Lockless.  
  
2.1 Introduction 
Clostridium difficile infection (CDI) has become one of the most common hospital 
acquired infections in the United States (7, 86). Antibiotic use is the major risk factor 
associated with CDI (86). Treatment of potential hosts with broad spectrum antibiotics 
leads to major alterations in the normally-protective colonic microbiota and permits 
colonization of that host by C. difficile spores (86). Though antibiotics (e.g., vancomycin) 
are available to treat CDI, the continued perturbation to the colonic microbiota by these 
antibiotics leads to multiple rounds of recurring infections (10). It is for this reason that 
the Centers for Disease Control and Prevention have listed C. difficile as “an urgent threat” 
regarding the antibiotic associated threats to the United States (7). 
                                                 
*Reprinted with permission from “A Clostridium difficile alanine racemase affects spore 
germination and accommodates serine as a substrate” by Shrestha R., Lockless S.W., 
Sorg J.A., 2017. JBC, M117, 791749, Copyright [2017] by Journal of Biological 
Chemistry. 
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Although C. difficile is a strict anaerobe, it survives in aerobic environments and 
transmits between hosts in the spore form (87). Spores are metabolically dormant forms 
of bacteria and formed from vegetatively growing cells, often, upon nutrient limitation. 
During spore-formation, a vegetative cell asymmetrically divides into a mother cell 
compartment and a forespore compartment (88). Through coordinated gene expression, 
the two compartments mature the forespore into a multilayered spore that can resist harsh 
conditions (e.g., radiation, heat, antibiotics, etc.) (31). Spores are composed of a DNA-
containing core where much of the water has been replaced with dipicolinic acid [often as 
a calcium chelate (CaDPA)], an inner membrane, a thin peptidoglycan layer, a thick 
specialized peptidoglycan-containing cortex layer, an outer membrane, a coat layer and, 
in some organisms, an exosporium layer (31, 88, 89). 
 In a host, these spores must exit dormancy (germinate) to generate the actively 
growing, toxin-producing, cells that elicit the primary symptoms of disease. C. difficile 
spore germination is stimulated by the combinatorial action of certain bile acids and 
certain amino acids (60, 62, 74, 90). C. difficile spore germination is activated by cholic 
acid-class bile acids while chenodeoxycholic acids competitively inhibit cholic acid-
mediated germination (60, 62). Though bile acids are important for germination, they are 
not sufficient to activate germination on their own. Amino acids are also required for 
germination and the most effective co-germinant is glycine (60). However, other amino 
acids can function as co-germinants with varying efficiencies (e.g., alanine) (74). 
 In most organisms, germinants interact with their cognate receptors at the inner 
membrane of the spore (89). These ger-type germinant receptors bind to germinants and 
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lead to the release of CaDPA from the core in exchange for water (89). Subsequently, the 
spore cortex is degraded through the action of spore cortex lytic enzymes (SCLEs). C. 
difficile does not encode orthologues of the classical ger-type germinant receptor and, 
instead, uses a novel pathway for initiating spore germination where the CspC 
pseudoprotease is the bile acid germinant receptor (61, 88, 91). We hypothesized that 
CspC transmits a bile acid signal to the CspB protease which then cleaves the SCLE, pro-
SleC, to an active form (41, 92, 93). Activated SleC degrades the cortex leading to CaDPA 
release, due to osmotic changes in the core resulting from to cortex degradation (70, 93).  
 Recently, GerG and GerS were identified as important players in C. difficile spore 
germination. Encoded downstream of gerS is alr2, coding for an alanine racemase (71, 
73). Alanine racemases enzymatically convert L-alanine to the D-alanine stereoisomer and 
are known to be involved in spore development and germination (94, 95). During spore 
development, the alanine racemase converts the L-alanine germinant to the D-alanine 
inhibitor in order to prevent germination of the developing spore within the mother cell 
(55, 95-97). During B. subtilis spore germination, the alanine racemase converts L-alanine 
to D-alanine to suppress spore germination, a process termed ‘autoinhibition’ (97, 98); D-
alanine does not inhibit germination by other B. subtilis germinants and is specific to the 
GerA germinant receptor (55). Autoinhibition of spore germination occurs, presumably, 
until the abundance of L-alanine accumulates to sufficient levels to overwhelm the 
racemase and stimulate spore germination (95). In C. difficile only the L-form of alanine 
can trigger spore germination when added with taurocholic acid (TA) (74). Unlike what 
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is seen for B. subtilis spore germination, D-alanine does not inhibit germination by C. 
difficile spores (74). 
Interestingly, in the same study that identified GerS as a novel regulator of spore 
germination, inactivation of C. difficile alr2 had minimal impact on C. difficile spore 
germination when analyzed in rich medium (71). However, we hypothesized that alr2 may 
play an important role during spore germination in defined medium in the presence of 
alanine and TA as germinants. Indeed, we find that C. difficile alr2 mutants play an 
important role during spore germination – by converting D-alanine to the L-alanine co-
germinant. Interestingly, we find that Alr2 also interconverts L- and D-serine and that 
these amino acids are germinants for C. difficile spores. Finally, we determine that the 
affinity of Alr2 for amino acids may be destabilized by the bound cofactor because an 
Alr2 mutant that does not bind to its cofactor has an affinity for L / D alanine that is ~80x 
greater to that of the wildtype protein. Our results shed new light on mechanisms of C. 
difficile spore germination and suggest that C. difficile spores are equipped to recognize 
more amino acids as co-germinants than previously thought. 
 
2.2 Materials and Methods 
2.2.1 Strains and growth conditions 
C. difficile UK1 and derivatives were routinely grown at 37 °C in an anaerobic 
environment (10% H2, 5% CO2, 85% nitrogen) in Brain Heart Infusion supplemented with 
5 g / L yeast extract and 0.1% L-cysteine (BHIS) medium. E. coli was routinely grown in 
LB medium at 37 °C. B. subtilis was grown in LB medium. Antibiotics were added when 
23 
necessary (20 µg / mL chloramphenicol, 10 µg / mL thiamphenicol, 20 µg / mL 
lincomycin, 50 µg / mL kanamycin, 100 µg / mL ampicillin). 
2.2.2 Molecular Biology 
A mutation in C. difficile alr2 mutant was generated by retargeting the pJS107 
TargeTron plasmid, as described previously (61). Primers to generate C. difficile RS07 
and its complementing plasmid (pRS89) are listed in Table 3. Briefly, potential insertion 
sites for the group II intron were determined using the Targetronics algorithm 
(Targetronics, LLC.) and a potential insertion site was identified in the sense orientation 
at nucleotide 138 of the alr2 coding sequence based upon the sequenced C. difficile 
R20291 strain (C. difficile UK1 is not a sequenced strain but is closely related to the 
R20291 strain). A gBlock (Integrated DNA technologies) was synthesized and cloned into 
the TOPO-ZeroBlunt cloning vector and transformed into E. coli DH5α, generating 
pRS85. The retargeting fragment was sub-cloned into pJS107 at the HinDIII and BsrGI 
restriction sites, transformed into E. coli DH5α, yielding pRS86. The alr2 complementing 
plasmid (pRS89) was generated by amplifying the P1 promoter and the alr2 coding 
sequences using Phusion DNA polymerase (New England Biolabs). The resulting 
fragments were cloned into the B. subtilis – C. difficile shuttle vector, pJS116, at the XbaI 
and XhoI restriction sites using Gibson Assembly (99). The plasmid used to express 
recombinant Alr2 protein was created by amplifying the alr2 gene from C. difficile UK1 
using primers 5’pET_alr and 3’pET_alr (Table 3) and cloned into expression vector 
pET222b at the XhoI and NdeI restriction sites. The resulting plasmid was named pJS164. 
Similarly, the plasmid for the expression of AlrK39A was created by using overlapping PCR 
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using primers 5’alr L39A and 3’alr L39A (Table 3), to create a change AA into GC such 
that the resulting amino acid would change from lysine to alanine. The amplified fragment 
with the mutation was stitched together using 5’ alr and 3’ alr primers and cloned into 
pET22b expression vector at XhoI and NdeI site and the resulting plasmid was named as 
pRS100. The DNA sequences for all plasmids were verified by sequencing (Eurofins). 
2.2.3 Conjugation and mutant selection 
Both pRS86 and pRS89 were inserted into C. difficile UK1 via conjugation with 
the Tn916-containing B. subtilis BS49 as a donor. B. subtilis was transformed with these 
plasmids following standard protocols and transformants were confirmed using PCR. B. 
subtilis BS49 containing pRS86 or pRS89 was conjugated with C. difficile UK1, as 
described previously (61). After screening for tetracycline-sensitive and thiamphenicol-
resistant colonies (transposon-negative, plasmid-positive), the colonies were confirmed to 
have the desired plasmid using PCR. To isolate a TargeTron insertion into alr2, the above 
isolates were spread onto BHIS plates containing 20 µg / mL lincomycin and incubated 
for 24-36 hrs to obtain colonies. Lincomycin-resistant colonies were isolated and tested 
for insertion of TargeTron by PCR using the primers 5’alr and 3’alr (Table 3). An isolate 
with the desired group II intron insertion was identified and this strain was renamed C. 
difficile RS07. 
2.2.4 Preparation of spores 
All spores were purified from BHIS agar medium as described previously (60, 61, 
90). Briefly, both wild type C. difficile UK1 and C. difficile RS07 were grown on BHIS 
agar medium and C. difficile RS07 pRS89 was grown on BHIS agar media supplemented 
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with 5 µg / ml thiamphenicol. Strains were grown for 4-5 days before isolating the growth 
and suspending in 1 ml sterile water per plate. The suspension was stored overnight at 4 
°C to promote release of the spores from the mother cells. The suspensions were then 
washed five times with sterile water to remove cell debris. The resulting spores were 
purified using a bed of 60 % sucrose by centrifuging at 4,000 x g for 30 minutes. After 
centrifugation, the sucrose was removed and the spores at the bottom of the tube were 
isolated and washed five times with sterile water to remove the sucrose. The spores were 
>99 % pure and heat-activated at 65 °C for 30 min before use. 
2.2.5 Spore germination 
Spore germination was analyzed at 25 °C or 37 °C using both a DPA release assay 
and an OD assay both. All assays were carried out in 100 µL total volume using buffer 
containing a final concentration of 50 mM HEPES, 100 mM NaCl (pH 7.5), 10mM TA 
and varying concentrations of amino acids. The DPA release assay was performed, as 
described previously, using final spore density of 0.5 OD with 30mM of amino acids and 
250 µM of TbCl3 in a 96-well plate reader at low PMT settings (Excitation at 270, 
emission at 420nm) (70). The OD-based germination assay was also carried out using a 
plate reader at 595 nm with final 0.5 OD spores and 30mM of amino acids. 
For the calculation of EC50, the DPA release assay was used at 37 °C with 
increasing concentrations of amino acids (0 – 200 mM and a final OD600 = 0.3 spores). 
The rates of germination were determined using the slopes of the linear portions of the 
germination plots. Data are reported as the averages from three independent experiments 
with one standard deviation from the mean. 
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2.2.6 Purification of Alr2 and AlrK39A 
pJS164 and pRS100 were transformed into E. coli BL21(DE3) slyD::kan. To 
express and purify Alr26His, cells were grown at 37 °C to an OD600 = 0.8 in 2xTY medium 
supplemented with ampicillin before inducing for 4 hours at 37 °C in the presence of 500 
µM IPTG. Cells were pelleted at 6,000 x g for 15 minutes in a Sorvall centrifuge (Beckman 
Coulter). Pellets were suspended in lysis buffer (LIB) containing 50 mM Tris-HCl (pH 
7.5), 250 mM NaCl, 1 mM pyridoxyl-5’-phosphate (PLP), 1 mM (tris (2-carboxyethyl) 
phosphine (TCEP), 15 mM imidazole and protease inhibitor (1mM PMSF) before freezing 
at -80 °C. 
The cell pellets were thawed and suspended in LIB (25 ml per 1L of cell pellet). 
Lysozyme and DNase were added and the cell suspension was incubated on ice for 30 
min. Cells were lysed using sonication. The sonicated extract was clarified by 
centrifugation at 15,000 X g for 30 minutes at 4 °C. Alr26his was purified from the extract 
by nickel-affinity chromatography. Beads were washed once in wash buffer LIB 
containing 30 mM imidazole. The recombinant protein was eluted from the beads using 
the wash buffer with 500 mM imidazole. The eluted protein was dialyzed in LIB for 3 hrs 
and further purified by gel filtration chromatography (Akta Pure, GE Health) on a 
Sephedex G200 size exclusion column. Protein was injected and separated at 1 mL / min 
using LIB. Protein was detected at 280 nM and the eluted protein was collected (Figure 
S3). 
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2.2.7 Enzymatic assays and HPLC separation of stereoisomers 
L- to D-alanine and L- to D-serine conversion (and vice versa) was initiated by 
adding 500 ng of purified Alr2 to 50 mM amino acid in 50 mM Tris-HCl (pH 7.5), 250 
mM NaCl, 1 mM PLP and 1 mM TCEP [total reaction volume was 100 µL (155 nM)]. 
The reactions were incubated at 37 °C for 1 hour. 
 In order to assay for the presence of L and D forms of the tested amino acids, 200 
µL of 1 % FDAA (Marfey’s reagent) in acetone and 40 µL of 1 M sodium bicarbonate 
was added to the reaction conditions above and incubated for 1 hour at 40 °C (100). After 
the 1 hour incubation, 20 µL of 2 M HCl was added to stop the reaction. The reacted 
material was separated by reverse-phase HPLC (Prominence system, Shimadzu) using a 
Thermo Scientific Synchronis C18 column. Three microliters of the reacted material was 
injected and separated at a 0.65 ml / min flow rate of buffer A (50 mM triethylammonium 
phosphate pH 3.5 in 25% methanol) and a gradient of 0 % buffer B (50 mM 
triethylammonium phosphate pH 3.5 in 75 % methanol) to 100 % buffer B in 40 min 
before returning to 0 % buffer B for another 30 minutes (70 minutes total time). Elution 
of the FDAA and FDAA-labeled compounds was detected by absorbance at 340 nm and 
peak area was quantified. 
2.2.8 Isothermal Titration Calorimetry 
All ITC experiments were done using a MicroCal iTC200 System (Malvern) at a 
constant temperature of 25 °C. The ITC base buffer was 50 mM Tris-HCl (pH 7.5), 250 
mM NaCl and 1 mM PLP. In the ITC chamber, wild-type Alr2 was used at a concentration 
of 32 – 45 µM in the ITC base buffer, while Alr2K39A was at 100 µM. In the syringe, D- 
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and L-alanine ligands were dissolved in ITC base buffer at 200 mM for wild-type protein 
or 20 mM for the Alr2K39A experiments, and D- and L-serine were made to 200 mM. All 
solutions were filtered or centrifuged at 18,000 x g for 5 minutes prior to use. 
Thermograms were processed and fit using a single-ligand model (with n fixed to unity), 
using Origin software, to obtain K (association constant) and ΔH (enthalpy). The 
dissociation constant (KD) was calculated from the relationship KD=1/K. 
 
2.3 Results 
2.3.1 C. difficile alr2 is not required for spore germination in rich medium 
C. difficile alr2 (encoding an alanine racemase) is the sixth most expressed 
sporulation protein (101). Prior work has shown that, though highly expressed, Alr2 seems 
to play little to no role during C. difficile spore germination in rich medium supplemented 
with TA germinant (71). However, given the diverse signals present in rich medium, we 
hypothesized that C. difficile alr2 may play a role similar to what is observed in other 
spore-forming bacteria by affecting germination in response to L-alanine. Towards this 
goal, we generated a TargeTron mutation in C. difficile UK1 alr2. When suspended in 
rich, BHIS, medium supplemented with TA (BHIS-TA), wild type C. difficile UK1 spores 
rapidly germinate as shown as a decrease in the optical density of the suspension (Figure 
4A). Similarly, C. difficile RS07 (alr2::ermB) spores also rapidly germinated in BHIS-TA 
(Figure 4B) and when the alr2 disruption was complemented by expressing alr2 from a 
plasmid, no difference was observed compared to the other tested strains (Figure 4C). 
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These results confirm prior observations that Alr2 plays little role during germination of 
C. difficile spores in rich medium. 
 
Figure 4. Alr2 does not contribute to germination by C. difficile spores in rich 
medium. Purified spores from (A) wildtype C. difficile UK1 or (B) C. difficile RS07 
(alr2::ermB) or (C) C. difficile RS07 pRS89 (palr2) were suspended in rich, BHIS 
medium (●) or BHIS supplemented with 10 mM TA (■) at 25 °C. The OD600 of the 
suspension was monitored over time. Data points represent the average from three 
independent experiments and error bars represent the standard deviation of the mean. 
 
 
2.3.2 C. difficile alr2 is dispensable for germination in response to L-alanine but 
essential for germination in response to D-alanine 
  To test the effects of an alr2 disruption on C. difficile spore germination, we analyzed 
spore germination in defined medium. C. difficile UK1 spores were suspended in buffer 
supplemented with TA and glycine or TA and L-alanine or TA and D-alanine and  
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Figure 5. Alr2 affects L/D-alanine-mediated germination by C. difficile spores. 
Purified spores from (A) wildtype C. difficile UK1 or (B) C. difficile RS07 (alr2::ermB) 
or (C) C. difficile RS07 pRS89 (palr2) were suspended germination buffer supplemented 
with TA alone (●), or supplemented with glycine (■) or L-alanine (▲) or D-alanine (▼). 
CaDPA release from the germinating spores was monitored at 37 °C as an increase in 
Tb3+ fluorescence over time. Data points represent the average from three independent 
experiments and error bars represent the standard deviation of the mean. 
 
 
 germination was monitored at 25 °C (Figure S1). As expected, wild type C. difficile UK1 
germinated in response to glycine and in response to L-alanine (Figure S1A). C. difficile 
UK1 spores did not initiate germination in response to TA and D-alanine. When C. difficile 
RS07 was tested for germination in response to TA and glycine or TA and L-alanine or 
TA and D-alanine, we observed a decrease in the ability of the strain to germinate in 
response to L-alanine but not in response to glycine (D-alanine, again, had no effect on C. 
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difficile spore germination) (Figure S1B). This defect in germination in response to L-
alanine could be complemented to near wild type levels (Figure S1C). 
To date, most germination assays in our lab, and others, were performed at room 
temperature. Though germination often proceeds quickly at this temperature, we reasoned 
that some C. difficile spore enzymes may best function at 37 °C (a physiologically-relevant 
temperature). Therefore, we again tested germination of wildtype C. difficile spores in 
response to TA and glycine or TA and L-alanine or TA and D-alanine. As expected, 
wildtype C. difficile UK1 spores germinated in response to TA and glycine or TA and 
alanine (Figure 5A). Surprisingly, C. difficile UK1 spores also germinated using D-alanine 
as a co-germinant with TA (Figure 5A). C. difficile RS07 spores germinated similar to 
wildtype UK1 spores in TA and glycine or TA and L-alanine (Figure 5B). Interestingly, 
C. difficile RS07 spores were unable to respond to D-alanine as a co-germinant with TA 
at the concentration tested (Figure 5B). This defect in germination could be restored by 
expressing alr2 from a plasmid (Figure 5C). These results suggest that the Alr2 alanine 
racemase has a role in recognizing D-alanine as a co-germinant or that it converts D-
alanine to L-alanine which then functions as a co-germinant with TA. 
2.3.3 C. difficile RS07 spores more-readily germinate in response to L-alanine as a 
co-germinant with TA 
Alanine racemases are known to be involved in spore germination, but all studied 
to date are thought to covert L-alanine to D-alanine which then acts as an inhibitor of L-
alanine-mediated germination and it is unclear if D-alanine conversion to L-alanine is 
important in these organisms. During germination, C. difficile alr2 may convert D-alanine 
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to L-alanine which would stimulate spore germination in combination with TA. However, 
because L-alanine is a germinant (and D-alanine does not inhibit C. difficile spore 
germination) if Alr2 converts L-alanine to D-alanine during germination, C. difficile RS07 
spores may be more sensitive to the L-alanine co-germinant. To quantify this, we 
determined the EC50 values for L-alanine in C. difficile UK1 spores, C. difficile RS07 
spores and C. difficile RS07 palr2 spores. Though spore germination is a multi-enzyme 
process, these kinetic measurements allow for the quantitative interaction of the spores 
with activators and inhibitors of germination (80, 102-108). When C. difficile UK1 spores 
were suspended in buffer supplemented with TA and increasing concentrations of L-
alanine we observed an increase in the germination rate. Using the rates and concentrations 
tested, we found that wildtype C. difficile spores had an EC50 of approximately 5.5 mM 
for L-alanine (Table 1). C. difficile RS07 spores were more sensitive to L-alanine as a co-
germinant with an EC50 value of 2.7 mM suggesting that Alr2 is able to convert L-alanine 
to D-alanine (Table 1). When the complemented strain was analyzed, the EC50 value was 
higher than wildtype, 10.7 mM, suggesting that overexpression of Alr2 drives L-alanine 
to D-alanine more than what is observed in wildtype (Table 1). 
Next, we determined the EC50 values for D-alanine during spore germination. C. 
difficile UK1 demonstrates an EC50 of 11.5 mM for D-alanine. If Alr2 is converting D-
alanine to L-alanine during germination, the EC50 value should increase in C. difficile 
RS07. Indeed, C. difficile RS07 spores were less sensitive to D-alanine as a germinant and 
yielded an EC50 value of 24.2 mM, weaker than wildtype. When alr2 was expressed from 
a plasmid, the EC50 decreased to 6.6 mM due to its conversion to L-alanine. The EC50 of 
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C. difficile RS07 palr2 with D-alanine was similar to the EC50 of wildtype spores and L-
alanine. Importantly, because Alr2 affected germination in response to L-alanine and D-
alanine, the EC50 values for C. difficile UK1 are an approximation for these amino acids 
(some of the L-alanine is converted to D-alanine and vice versa during germination). 
Taken together, these results suggest that D-alanine can be converted to L-alanine which 
functions as a co-germinant. Moreover, these results demonstrate that D-alanine, itself, is 
a co-germinant for C. difficile spores. 
Table 1 EC50 values (mM) for amino acids and the C. difficile spore 
C. difficile strain 
UK1 (wildtype) RS07 (alr2::ermB) RS07 pRS89 
(alr2::ermB palr2) 
L-alanine 5.5 ± 1.1 2.7 ± 1.8 10.7 ± 2.5 
D-alanine 11.5 ± 2.3 24.2 ± 6.6 6.6 ± 1.0 
L-serine 8.2 ± 0.8 2.5 ± 1.7 4.9 ± 0.5 
D-serine 7.8 ± 1.2 19.1 ± 5.0 CND 
The average and standard deviation for three biological replicates are shown. 
CND: could not determine 
EC50: concentration that achieves half-maximum germination rate 
2.3.4 Alr2 interconverts L-serine and D-serine 
A prior study determined a crystal structure of a C. difficile alanine racemase (109). 
Though not known at the time, this racemase is Alr2. When recombinantly expressed and 
purified Alr2 (Figure S2) was suspended in reaction buffer, reacted with L or D-alanine 
before labeling and separating by HPLC. As shown in Figure 6A, when incubated with L- 
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Figure 6. Alr2 interconverts L/D alanine and serine. Recombinantly expressed and 
purified Alr2 was incubated with (A) L-alanine or (B) L-serine or (C) D-serine for 1 hour. 
The reaction was labeled with FDAA and separated by HPLC. The HPLC retention times 
of each amino acid were determined using labeled amino acid standards. (D) Peak areas 
from each reaction were quantified and presented as % product generated from a reaction 
involving either L-alanine, or D-alanine, etc. and each data point is shown. Each bar 
represents the average peak area from three technical replicates. The error bars represent 
the standard deviation from the mean and, in most cases, are smaller than the bars. 
 
 
 
alanine, Alr2 converted L-alanine to an approximately equal amount of D-alanine (Figure 
6D); we use >98% pure D or L-amino acid for these studies and the opposite enantiomer 
is extremely low in these studies (Figure S3). During the course of these experiments, we 
included L-serine as a would-be negative control for conversion. To our surprise, Alr2 
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converted L-serine to an approximately equal amount of D-serine (Figure 6B). When 
tested with D-serine, Alr2 did not convert as much and nearly 75% of the D-serine (Figure 
6C, quantified in Figure 6D) remained in the D-form. Because Alr2 converted L- and D-
serine, we tested every other, soluble, amino acid (data not shown). No other amino acid 
was converted by Alr2 indicating that Alr2 has specificity to the L and D forms of alanine 
and serine. 
 
 
Table 2 ITC analysis of Alr2 and Alr2K39A binding to L/D alanine & serine 
 Alr2WT Alr2K39A 
 KD (mM) ΔH KD (µM) ΔH 
L-alanine 9.2 ± 0.7 -7 ± 0.7 64 ± 6 -1.1 ± 0.1 
D-alanine 9.2 ± 0.4 -7.8 ± 0.7 46 ± 9 -1.7 ± 0.1 
L-serine 14 ± 1 -16 ± 1 CND CND 
D-serine 17 ± 1 -21 ± 0.2 CND CND 
The average and standard error of the mean for at least three technical replicates are 
shown. The differences in binding between L-alanine and D-alanine or L-serine and D-
serine are not statistically significant. The difference in the binding of Alr2 to L-alanine 
and L-serine or D-alanine and D-serine are significant (p-val < 0.05 and p-val < 0.01, 
respectively). 
CND: could not determine 
 
 
2.3.5 L- and D-serine are co-germinants for C. difficile spores 
 
Because Alr2 interconverted L and D serine, we reasoned that C. difficile spores 
may respond to L-serine as a germinant. Thus, we determined the EC50 values for L- and 
D-serine during C. difficile spore germination, as described above (Table 2). Wildtype C. 
difficile UK1 displayed an EC50 for L-serine of 8.2 mM. This EC50 decreased to 2.5 mM 
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in the absence of alr2. Complementation of C. difficile RS07 lead to a decrease in EC50 
from the mutant levels to 4.9 mM but did not restore the EC50 to wildtype levels. 
Interestingly, C. difficile spores showed an EC50 for D-serine similar to that of L-serine. 
Also, similar to C. difficile RS07 and D-alanine, D-serine was a poor germinant in the 
absence of alr2 (EC50 = 19.1 mM). Unfortunately, we were unable to complement the 
phenotype in response to D-serine, for unknown reasons. These results suggest that both 
L- and D-serine are co-germinants C. difficile spores. 
2.3.6 Determining the affinity of Alr2 and Alr2K39A to L/D alanine and serine 
Previously, kinetic analysis of L- to D-alanine conversion (and vice versa) was 
used to determine the affinities of Alr2 to the alanine isoforms (109). Because we found 
that Alr2 can convert L- and D-serine, we tested the affinity of Alr2 to alanine and serine 
by isothermal titration calorimetry (ITC) (Figure 7). As shown in Figure 7A, when L-
alanine was injected into the ITC cell, we observed exothermic binding between Alr2 and 
L-alanine which could be saturated. We found that Alr2 had similar affinities for L-alanine 
(9.2 mM) and D-alanine (9.2 mM). The affinities for L-serine (14 mM) and D-serine (17 
mM) were weaker (Table 2). Because the ITC method injects ligand into the ITC cell, 
Alr2 converted the injected ligand to its isomer (Figure S4). 
Because of the conversion of the L to D-form (and vice versa) in the ITC cell, the affinity 
of Alr2 for each of the tested amino acids could be an average of the affinities for tested 
and converted amino acids. For this reason, we engineered a mutation that disrupts the 
binding of the co-factor that is essential for catalysis (pyridoxal 5’ phosphate). The 
Alr2K39A mutant was confirmed to be enzymatically dead by HPLC analysis of Alr2K39A 
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reactions with L- and D-alanine (data not shown). When the binding of Alr2K39A to L- or 
D-alanine was tested by ITC, we observed significantly less signal (Figure 7B) compared 
to that of wildtype Alr2 (Figure 7A). However, we observed a signal that could be 
saturated (Figure 7B). From this data, we determined that Alr2K39A had an affinity of 65 
µM for L-alanine and 50 µM for D-alanine (140 times that of wildtype for L-alanine and 
184 times that of wildtype for D-alanine). Unfortunately, we could not determine the 
affinity of AlrK39A and L-serine or D-serine, the signal to noise ratio was much too great 
to yield usable data. 
 
 
Figure 7. Binding of Alr2WT and Alr2K39A to L-alanine. Recombinantly expressed and 
purified (A) Alr2WT or (B) Alr2K39A was tested for their ability to bind to L-alanine by ITC. 
The thermograms are shown in the top panels. A binding isotherm was generated from the 
total heat following each ligand injection and is plotted in the bottom panel. The data are 
representative of at least three technical experiments. The summarized data can be found 
in Table 2. 
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2.4 Discussion 
 Spore germination is most-often triggered by L-alanine (88). In the model spore 
forming organism, B. subtilis, L-alanine interacts with the GerAA-AB-AC germinant 
receptor (89). This interaction leads to the release of CaDPA from the spore core and 
subsequent cortex degradation. The GerA germinant receptor is conserved across most 
spore-forming bacteria (110). In B. anthracis, and other organisms, L-alanine is a 
germinant whose action is dependent on the presence of the GerA germinant receptor. 
Importantly, C. difficile does not encode orthologues of the gerA germinant receptor but 
germinates through a novel spore germination pathway (61, 70, 88, 91, 93). 
 The bile acid germinant receptor, CspC, activates germination through an 
unknown mechanism (61). Subsequently, the CspB protease activates pro-SleC by 
cleaving the N-terminus from the protein, generating active cortex hydrolase (92). SleC 
then degrades the cortex resulting in osmotic changes that are perceived at the inner spore 
membrane (70, 93). This change in osmotic pressure at the inner spore membrane is 
relieved by the SpoVAC mechanosensing protein and results in CaDPA release from the 
core (70). Though bile acids are necessary to trigger germination, they are not sufficient. 
An amino acid signal is required to function as a co-germinant (60). 
 The most effective amino acid co-germinant is glycine (60). However, other amino 
acids can function as co-germinants (88). Previously, Howerton, Ramirez and Abel-Santos 
(2011) found that L-alanine could function as a co-germinant with TA for C. difficile 
spores (74). In their study, they found that D-alanine did not inhibit L-alanine-mediated 
spore germination, unlike what is observed in other spore-forming bacteria. Importantly, 
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the authors found that D-alanine did not function as an activator of spore germination at 
30 °C (74). Herein, we found that D-alanine can stimulate spore germination in 
combination with TA at 37 °C. Moreover, in the same study, L-serine was nearly inactive 
as a co-germinant (L-serine generated ~5% germination when compared to glycine); D-
serine was not tested (74). However, we find that both L-serine and D-serine can function 
as co-germinants for C. difficile spores at 37 °C. Our data suggest that temperature is an 
important consideration when determining activators and inhibitors of C. difficile spore 
germination. 
 Surprisingly, C. difficile Alr2 converted L-serine to D-serine (and vice versa). The 
affinities of Alr2 to L-serine and D-serine were similar, but the difference was not 
statistically significant. When tested for the ability to convert L-serine to D-serine, we 
observed that Alr2 generated nearly 50 % D-serine, suggesting that Alr2 efficiently 
converts L-serine to D-serine. When Alr2 was given with D-serine as a substrate, Alr2 
only generated approximately 25 % L-serine from 100 % D-serine. Because the binding 
affinities of Alr2 and L- or D-serine are similar, this could indicate that the rate of 
conversion of D-serine to L-serine is much slower than the reverse reaction. Due to the 
conversion of L / D alanine and serine during ITC, we tested the binding of Alr2K39A to 
these amino acids. Though the KD for Alr2K39A and L- and D-serine could not be 
determined due to a low signal to noise ratio, we found that the KD for L- and D-alanine 
to be much lower than the KD for the wildtype protein (Table 2). This suggests that the 
PLP co-factor may destabilize the interaction of Alr2 with its substrate, potentially as part 
of the catalytic mechanism. 
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Alanine racemases play important roles during the growth of Gram-negative and 
Gram-positive bacteria (94). These racemases are used to convert L-alanine to the D-
alanine that is used to synthesize stem peptides during cell wall synthesis (94). As such, 
these proteins can be targeted by antibiotic treatment to prevent cell wall synthesis. D-
cycloserine is a commonly used antibiotic that targets alanine racemase, indicating that 
the racemization of alanine is important for cellular physiology (109). Alr2 can be 
inactivated by D-cycloserine but C. difficile is naturally resistant to the antibiotic action 
of D-cycloserine and D-cycloserine is included in medium that is selective for C. difficile 
growth (109, 111). This suggests that the Alr2 that is incorporated into the C. difficile 
spores is unlikely to be used during cell wall synthesis. C. difficile encodes other amino 
acid racemases. For example, CDR20291_2507 is annotated as a putative alanine 
racemase. However, there are several other putative amino acid racemases, including a 
putative VanTG orthologue (serine / alanine racemase). It is likely that one of these other 
racemases is insensitive, or has reduced sensitivity, to D-cycloserine. We tested the effects 
of pre-exposure of D-cycloserine to C. difficile spores as a means to inactivate Alr2 to 
prevent the conversion of amino acids in the C. difficile spore. Unfortunately, D-
cycloserine functioned as a weak co-germinant (data not shown). Because of the 
background spore germination generated by D-cycloserine, we could not inactivate Alr2 
chemically. 
Autoinhibition of spore germination is important for the development of a spore 
and ensuring that the spore germinates under appropriate conditions (95, 97). Alanine 
racemase is important for autoinhibition by preventing premature germination of the 
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developing spore within the mother cell or under less-than-suitable environmental 
conditions. We did not observe a difference between spores produced by the wildtype 
UK1 strain and spores produced by the alr2 mutant strain. Because C. difficile spore 
germination is activated in response to bile acids and an amino acid co-germinant, it is not 
surprising that the alr2 mutation did not affect spore formation. The alr2 mutation resulted 
in an increased sensitivity to L-alanine and a decreased sensitivity to D-alanine (Table 1). 
Because D-alanine does not inhibit C. difficile spore germination, autoinhibition is 
minimal during C. difficile spore germination and only applies to the conversion of a very 
good germinant to a weak germinant. 
A prior study analyzed the proteome of C. difficile strain 630 spores (112). In this 
study, Alr2 was found to be extracted by incubating spores in 2-mercaptoethanol (a 
condition that solubilizes coat proteins) (112). Though the location of Alr2 has not been 
determined, this would suggest that it resides outside of the spore core where it would be 
available to convert L / D alanine and serine. In this same study, no serine racemase was 
found (112). But, the authors found that C. difficile 630 CD3237 (a putative proline 
racemase) was present in the spore extracts. Though proline has not been described as a 
germinant for C. difficile spores, the inclusion of a proline racemase into the spore could 
signal the importance of proline racemization for C. difficile physiology, potentially for 
use in Stickland metabolism (113). 
This study builds upon the hypothesis that the unidentified amino acid germinant 
receptor has broad specificity. Prior work has shown that the amino acid germinant 
receptor may require both a free carboxylate and a free amino a group (74). In this study, 
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some amino acids did not function as co-germinants (e.g., L-histidine or L-serine). Our 
findings suggest that either there are multiple receptors that each recognize different amino 
acids as co-germinants, or that the amino acid germinant receptor can accommodate a 
diverse range of amino acids (both L and D forms). Because studies on C. difficile spore 
germination have been conducted at lower than physiological temperatures, it would be 
worthwhile to revisit the requirements of the amino acids to function as co-germinants at 
37 °C. 
  
43 
 
 
Table 3 Oligonucleotides used in Chapter II 
Primer Name Primer sequence 
R20291_alr 138s 
(gBlock) 
TTCCCCTCTAGAAAAAAGCTTATAATTATCCTTATATGGCCATGGTGTGCGCCCAGATA
GGGTGTTAAGTCAAGTAGTTTAAGGTACTACTCTGTAAGATAACACAGAAAACAGCCA
ACCTAACCGAAAAGCGAAAGCTGATACGGGAACAGAGCACGGTTGGAAAGCGATGAG
TTACCTAAAGACAATCGGGTACGACTGAGTCGCAATGTTAATCAGATATAAGGTATAA
GTTGTGTTTACTGAACGCAAGTTTCTAATTTCGATTCCATATCGATAGAGGAAAGTGTC
TGAAACCTCTAGTACAAAGAAAGGTAAGTTAGCACCATGGACTTATCTGTTATCACCA
CATTTGTACAATCTG 
5’ alr CATGCAAAAAATAACAGTG 
 
3’ alr TTATTTTAGCAAATAACTGTTT 
 
5' pJS116_XbaI_P1-prom TACGAATTCGAGCTCGGTACCCGGGGATCCTCTAGACCAGTTGTAGATTCAGAGAAT
A 
3' alr_P1-Prom TGCCCATGTAGGCACTGTTATTTTTTGCATCACACCTCCTACTTCAGTTT 
5' P1-Prom_ alr TACAATGAATAAACTGAAGTAGGAGGTGTGATGCAAAAAATAACAGTGC 
3' pJS116_XhoI_alr CCAGTGCCAAGCTTGCATGTCTGCAGGCCTCGAGTTATTTTAGCAAATAACTGTTTA
TTT 
5'pET_alr GTTTAACTTTAAGAAGGAGATATACATATGCAAAAAATAACAGTGCCTACATG 
3'pET_alr ATCTCAGTGGTGGTGGTGGTGGTGCTCGAGTTTTAGCAAATAACTGTTTATTTGTAC 
5' alr L39A AAGATTTGTGGAGTAATAGCAGCTGATGCATATGG 
3' alr L39A GTCCATATGCATCAGCTGCTATTACTCCACAAAT 
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CHAPTER III 
HIERARCHICAL RECOGNITION OF AMINO ACID CO-GERMINANTS 
DURING Clostridioides difficile SPORE GERMINATION† 
 
In Chapter III, we analyzed the efficiency of amino acid to which putative amino 
acid germinant receptor is bound by measuring DPA release. 
 
3.1 Introduction 
Clostridioides difficile (recently renamed from Clostridium difficile (114, 115)) is 
a Gram-positive, spore-forming, obligately anaerobic human pathogen that causes 
symptoms ranging from mild diarrhea to life threatening colonic inflammation (116, 117). 
Antibiotic use is common in the healthcare environment, and prior antibiotic treatment, 
either related or unrelated to C. difficile infection (CDI), is the greatest risk factor for CDI. 
A healthy gut microbiota protects against CDI and the use of broad spectrum antibiotics 
disrupts the gut microbiota so that the gut becomes a suitable environment for C. difficile 
colonization (116-118). During colonization and disease, C. difficile forms metabolically 
dormant spores that are resistant to adverse environmental factors including most 
disinfectants (34, 88, 118). 
Bacterial endospores are metabolically dormant structures that some bacteria 
produce when the cells are under nutrient deprivation or other environmental stresses. 
                                                 
†Reprinted with permission from “Hierarchical recognition of amino acid co-germinants 
during Clostridioides difficile spore germination” by Shrestha R., Sorg J.A., 2018. 
Anaerobe, 49, 41-47, Copyright [2018] by Anaerobe. 
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Similar to what is observed in Bacillus subtilis, a model organism for studying spore 
germination, the C. difficile spore core contains DNA, RNA, and the proteins necessary 
for the spores to outgrow after germination initiates (34, 88). The core is rich in calcium 
dipicolinic acid (DPA) which contributes to the spores’ significant resistance to heat (31, 
32, 89, 119). The core is surrounded by an inner membrane, a germ cell wall layer, a cortex 
layer, an outer membrane, a spore coat layer and an exosporium layer (88). To initiate 
germination, small molecule germinants must penetrate these layers to interact with their 
receptors. Because C. difficile is found in the gut, the key germination signals that its 
spores respond to are bile salts, such as taurocholate (TA), and amino acids, such as 
glycine (60). Spore germination is a crucial step in causing CDI, therefore it is an attractive 
therapeutic target for treatment (61, 120). 
Though bile acids are essential signals for C. difficile spore germination, they are 
not sufficient (60, 61). C. difficile spores also require an amino acid signal (e.g., glycine) 
to trigger the germination process (60, 74, 104). Even though some of the amino acids that 
trigger germination in other organisms can activate germination in C. difficile, C. difficile 
does not encode orthologues of the well-studied ger receptors (61, 91). In fact, C. difficile 
spores germinate through novel spore germination pathway involving activation of a 
pseudoprotease, CspC, present within the cortex layers (88, 93). In our working model, 
when taurocholate binds to CspC, the protein becomes activated such that it transmits its 
signal to the CspB protease, by an unknown mechanism (70, 88, 93). Activated CspB 
cleaves pro-SleC into its active, cortex-degrading, form (41, 92). DPA is then released 
from the core, the core becomes hydrated, and the germinated spore prepares for from the 
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core, the core becomes hydrated, and the germinated spore prepares for outgrowth (70, 
93). 
Though bile acids are important, germination of C. difficile spores cannot occur 
without a co-germinant (historically an amino acid, but calcium may play an unknown 
role (77)) and the amino acid germinant receptor is still unknown. Amino acids are 
frequently used as germinants. For example, in B. subtilis, spores germinate in response 
to L-alanine or to the combination of L-asparagine, D-glucose, D-fructose and potassium 
ions (AGFK) (121). The GerA germinant receptor (a combination of GerAA, GerAB and 
GerAC proteins) of B. subtilis recognizes L-alanine as a germinant. Prior work has 
suggested two possibilities regarding the identity of the amino acid germinant receptor in 
C. difficile: (i) there are multiple amino acid-recognizing germinant receptors; or (ii) the 
receptor recognizes multiple amino acids as germinants (74). 
In C. difficile, glycine is the most effective co-germinant and can be found in most 
rich media and in an antibiotic-treated host environment; indeed glycocholate, a host 
derived bile acid, can be deconjugated to glycine and cholate (122, 123). Other L-forms 
of amino acids (e.g, L-alanine or L-cysteine) also trigger C. difficile spore germination 
when added with TA (74, 124). Yet, not all amino acids (e.g., L-lysine or L-methionine) 
were identified as co-germinants (74). 
Previously we showed that at a physiologically-relevant temperature, amino acids 
that were reported not to be co-germinants (124) did trigger germination when added with 
TA (e.g., D-alanine or D-serine). These results led us to revisit germination of other amino 
acids which have not been previously shown to stimulate germination at room 
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temperature. Since many enzymes have an optimal temperature of 37 ºC, we tested the 
germination with TA and other amino acids at room temperature as well as at 37 ºC. To 
quantify the interaction of the amino acids with the C. difficile spore, we calculated the 
EC50 values for many amino acids from the data generated from the DPA release assay, 
which serves as a measure for spore germination. Based on the EC50 values, we were able 
to rank the amino acids from most effective to least effective as co-germinants. However, 
a few other amino acids such as L-isoleucine, L-leucine, and L-valine were still not able 
to stimulate germination at 37 ºC. This leads us to two more hypotheses regarding the role 
of amino acids, (i) the amino acid receptor has specificity to certain amino acids and this 
specificity decreases as the temperature is increased to 37 ºC (e.g., in a host), (ii) any 
amino acid can act as the second signal, but the affinity of the amino acid for its receptor 
varies. 
3.2 Materials and Methods 
3.2.1 Strains and their growth conditions 
C. difficile strains UK1 (027 ribotype, (61, 103, 125)) and M68 (017 ribotype, 
(126, 127)) were grown on BHIS agar medium (37 g of brain heart infusion, 5 g of yeast 
extract and 1g of cysteine per liter) at 37 ºC under anaerobic conditions (10% H2, 5% CO2, 
85% N2) for 3-4 days before harvesting for spore purification. 
3.2.2 Spore purification 
Spores derived from the UK1 and M68 strains were purified as described 
previously (70, 93). Briefly, the strains were grown on BHIS agar medium (20-30 plates) 
before scraping into microcentrifuge tubes containing 1 mL sterile water and kept at 4 ºC 
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overnight. The suspension containing spores and vegetative cell debris was washed with 
water five times by centrifuging for 1 min at 14,000 x g per wash. Spores were combined 
into 2-4 mL of water and further purified with a sucrose gradient (added 2 mL spores on 
top of 8mL of 60% sucrose and centrifuged at 4,000 x g for 20 min). The supernatant 
containing cell debris was discarded and the remaining pellet was washed again five times 
with sterile water. The spores were stored at 4 ºC until use and heat activated at 65 ºC for 
30 minutes before use. 
3.2.3 Germination assay 
To compare the germination of spores at two different temperatures, spores was 
analyzed at 25 ºC and 37 ºC by measuring both OD600 and DPA release. For the OD assay, 
the germination was carried out in clear Falcon 96-well pates in a final volume of 100 µL 
and final concentration of 10 mM TA, 30 mM amino acid, 50 mM HEPES, 100 mM NaCl 
pH 7.5. All amino acids stocks were dissolved in water and pH was adjusted to 7.5 and 
filtered sterilized before use. 
Similarly, 96-well black opaque plates were used to measure DPA released from 
the spores when exposed to a final concentration of 10 mM TA, 30 mM amino acid, 250 
µM TbCl3, 50 mM HEPES, 100 mM NaCl at pH 7.5. Spores were added to final OD600 of 
0.5 and germination was analyzed for 1 hr using a plate reader (spectramax M3). Tb 
fluorescence was monitored at 275 nm excitation and 545 nm emission. 
3.2.4 Calculation of EC50 values 
DPA release was measured using concentration of solutions described earlier with 
some changes (80, 124). Various amounts of amino acids ranging from 0 mM to 500 mM 
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were used for the DPA release and this assay was run at 37 ºC for 2 hours. The values 
acquired from the DPA release were normalized and any DPA release that occurred in the 
absence of amino acid was subtracted before calculating the EC50 values for each amino 
acid. EC50 values were calculated by deriving a rate curve from slopes of the germination 
plot against time. All germination experiments were done in triplicate and the average 
mean and standard deviation values were reported. 
3.3 Results 
3.3.1 Effect of temperature on germination by C. difficile spores 
Bile acids are essential, but not sufficient, to stimulate C. difficile spore 
germination. Amino acids are a required second signal. The best amino acid co-germinant 
is glycine, but others can substitute (e.g., L-alanine) (60, 74, 88). Previously, we 
demonstrated that temperature plays an important role in germination of C. difficile spores; 
other amino acids were revealed to be co-germinants only when C. difficile spore 
germination was tested at 37 ºC (124). To further investigate the effect of this 
physiologically-relevant temperature on C. difficile spore germination, we compared the 
germination of glycine, L-alanine and D-alanine to induce germination at 25 ºC and at 37 
ºC (Figure 8). When C. difficile UK1 spores were germinated with TA and glycine at 25 
ºC, the OD of the spore suspension rapidly dropped and DPA was rapidly released from 
the spore core (Figure 8A). When germinated at 37 ºC, the rate of OD drop and DPA 
release increased (Figure 8B). We also observed the same trend for L-alanine (Figure 8C 
and 8D). When we tested D-alanine at 25 ºC, we observed little change in the OD of the 
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Figure 8. Comparison of C. difficile spore germination at 25 °C and 37 °C. Purified 
C. difficile UK1 spores were suspended in buffer supplemented with 10 mM taurocholate 
and 30 mM of the indicated amino acid. The change in OD600 during germination (▲) and 
the release of DPA (●) was measured over time at 25 °C (A, C, E) or 37 °C (B, D, F). 
Glycine (A & B), L-alanine (C & D) or D-alanine (E & F) were tested as co-germinants. 
The data represent the average of three independent measurements and error bars represent 
the standard deviation from the mean. 
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spore suspension and a minor amount of DPA release (Figure 8E). However, when 
analyzed at 37 ºC, D-alanine functioned as a strong co-germinant for C. difficile spores 
(Figure 8F). Although, the efficiency with which D-alanine functioned as a co-germinant 
was less than that of L-alanine and glycine. These results suggest that there may be a 
hierarchy for amino acids functioning as co-germinants at 37 ºC. 
3.3.2 Identifying other co-germinants for C. difficile spore germination 
Because D-alanine functioned as a co-germinant at 37 ºC but not at 25 ºC, we 
reasoned that there may be other amino acids that can act with TA to stimulate C. difficile 
spore germination at 37 ºC. Thus, we tested every other soluble amino acid for its ability 
to function as a co-germinant; L-tyrosine and L-tryptophan were insoluble. As we 
hypothesized, other amino acids were co-germinants with TA when incubated with spores 
at 37 ºC. For example, L-lysine was a very poor germinant at 25 ºC (Figure 9A) but led to 
a substantial decrease in the OD of the spores and an increase the release of DPA when 
tested at 37 ºC (Figure 9C). Importantly, not every tested amino acid functioned as a co-
germinant with TA. Incubation of C. difficile spores with TA and L-isoleucine at 25 ºC 
(Figure 9B) or at 37 ºC (Figure 9D) did not lead to an appreciable decrease in OD or DPA 
release. These results suggest that other amino acids function as co-germinants with TA 
but not all amino acids are recognized as co-germinants during C. difficile spore 
germination. 
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Figure 9. Analysis of the effects of different co-germinants on C. difficile spore 
germination. Purified C. difficile UK1 spores were suspended in buffer supplemented 
with 10 mM taurocholate and 30 mM of the indicated amino acid. The change in OD600 
during germination (▲) and the release of DPA (●) was measured over time at 25 °C (A 
& C) or 37 °C (B & D). L-lysine (A & B) or L-isoleucine (C & D) were tested as co-
germinants. The data represent the average of three independent measurements and error 
bars represent the standard deviation from the mean. 
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Table 4 EC50 values for amino acids and C. difficile UK1 spores 
Amino Acids C. difficile UK1 
EC50 (mM) 
glycine 0.19 ± 0.01 
L-alanine 1.1 ± 0.2 
taurine 2.5 ± 1.6 
L-glutamine 3.1 ± 2.1 
L-histidine 4.1 ± 1.6 
L-serine 5.6 ± 0.5 
L-arginine 6.1 ± 0.6 
L-lysine 13.8 ± 1.3 
L-threonine 14.4 ± 3.2 
D-alanine 15.1 ± 9.1 
D-serine 24.3 ± 1.6 
L-proline 28.5 ± 5.2 
L-methionine 35.2 ± 10.5 
D-lysine 72.8 ± 36.1 
L-glutamate 98.7 ± 45.6 
L-aspartic acid 115 ± 17 
L-leucine >500 mM 
L-isoleucine >500 mM 
L-valine >500 mM 
L-phenylalanine >500 mM 
L-tyrosine Not soluble 
L-tryptophan Not soluble 
L-cysteine Interfered with DPA measurements 
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Table 5 EC50 values for amino acids and C. difficile M68 spores 
Amino Acids C. difficile M68 
EC50 (mM) 
glycine 0.48 ± 0.2 
L-arginine 3.6 ± 0.7 
L-alanine 5.1 ± 0.7 
taurine 7.7 ± 1.9 
L-glutamine 10.1 ± 0.6 
L-histidine 12.4 ± 5.8 
L-lysine 18.5 ± 4.6 
L-serine 19.4 ± 4.2 
D-alanine 25.0 ± 6.6 
D-serine 54.4 ± 2.6 
D-lysine 56.9 ± 19.4 
L-methionine 58.7 ± 4.6 
L-threonine 59.8 ± 25.3 
L-proline 73.2 ± 18.0 
L-aspartic acid 425 ± 170 
L-glutamate CND 
L-leucine >500 mM 
L-isoleucine >500 mM 
L-valine >500 mM 
L-phenylalanine >500 mM 
L-tyrosine Not soluble 
L-tryptophan Not soluble 
L-cysteine Interfered with DPA measurements 
EC50 values were calcuated from the germination rate curves as described in the 
materials and methods. The values reported are the averages from three independent 
experiments with the standard deviation from the mean. 
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3.3.3 Determining the effectiveness of various amino acids as a co-germinant 
To test if there indeed is a hierarchical rank of amino acids that function as co-
germinants, we determined the EC50 values for each amino acid. These values have been 
used to provide information about how germinants interact with the C. difficile spore (74, 
80, 90, 102-105, 107, 108, 124, 128). To calculate the EC50 values we incubated C. difficile 
UK1 spores in buffer supplemented with 10 mM TA and increasing concentrations of 
tested amino acid; the pH of the germination solution was adjusted to pH 7.5 before spores 
were added. The release of DPA during C. difficile spore germination was monitored for 
up to 2 hours at 37 ºC. The values were normalized and plotted against time. From this 
data, the maximum rates of DPA release were determined and used to calculate the EC50 
using the Michaelis-Menten equation, as described previously (74, 80, 90, 102-105, 107, 
108, 124, 128). Indeed, we observed a hierarchical order of amino acids that can stimulate 
germination in combination with TA (Table 4). As expected, glycine functioned as the 
best co-germinant and yielded an EC50 of ~190 µM. This was followed by L-alanine (1.1 
mM), taurine (2.5 mM), L-glutamine (3.1 mM) and L-histidine (4.1 mM). For the C. 
difficile UK1 strain the order was glycine > L-alanine > taurine > L-glutamine > L-
histidine > L-serine > L-arginine > L-lysine > L-threonine > D-alanine > D-serine > L-
proline > L-methionine > D-lysine > L-glutamate > L-aspartic acid. 
In order to determine if spores from a different C. difficile isolate germinate with 
the same rank order of amino acids, we determined EC50 values for each amino acid and 
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C. difficile M68 spores. There was a slight difference in the rank order for the two strains 
of C. difficile that we tested (Table 5). C. difficile M68 yielded a rank order of: glycine > 
L-arginine > L-alanine > taurine > L-glutamine > L-histidine > L-lysine > L-serine > D-
alanine > D-serine > D-lysine > L-methionine > L-threonine > L-proline > L-aspartic acid. 
The most effective amino acid co-germinant was glycine and the least effective 
co-germinant was L-aspartic acid for both the strains. Unfortunately, we could not 
determine the EC50 values for the remaining amino acids. Even though L-cysteine was 
shown to be a germinant in a prior report (74), L-cysteine interfered with the DPA release 
assay. L-tyrosine and L-tryptophan were not soluble. L-phenylalanine, L-valine, L-
leucine, L-isoleucine, L-asparagine were very poor germinants at the concentrations that 
were soluble. 
3.4 Discussion 
Apart from the bile acid signal, amino acids are also an important signal for C. 
difficile spore germination (88). Glycine was first identified as the co-germinant required 
to initiate C. difficile spore gerimination, though other amino acids could substitute for 
glycine (60, 74). Later, the requirements for the amino acid structure in functioning as a 
co-germinant were tested by Howerton & Abel-Santos (74). Here, the authors found that 
the EC50 for glycine was approximately 8.7 mM
2 for the C. difficile CD630 strain, using 
the OD assay as a readout . Importantly, these two studies analyzed germination at either 
room temperature or 30 ºC (60, 74). Recently, we found that when C. difficile spore 
germination occurs at 37 ºC, the spores recognize amino acids previously reported to not 
activate germination (e.g., D-alanine) (124). Therefore, we hypothesized that other amino 
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acids may be recognized by the spore when tested at physiologically relevant 
concentrations. 
When tested at 37 ºC, we observed that C. difficile spores recognized a diverse set 
of amino acids as co-germinants. Using two different C. difficile strains (UK1 and M68, 
ribotypes 027 and 017, respectively), we found that glycine is the most preferred amino 
acid co-germinant (Table 4). By using kinetic analysis of spore germination, we calculated 
the EC50 of glycine to be 190 µM and 420 µM for C. difficile UK1 and C. difficile M68, 
respectively (Table 4, Table 5). These values are below the previously-reported value for 
glycine (74). There are several factors that might have affected germination in response to 
these amino acid co-germinants. For example, the temperature previously used to test 
germination, strain considerations and the assay conditions. All prior studies that 
determined the EC50 values for germinants / co-germinants and the C. difficile spore used 
the OD assay for the measurements (74, 80, 90, 102-104, 128). Here, we used a DPA 
release assay to calculate the EC50 in order to test germination at 37 ºC. The SpectroMax 
plate reader we routinely use for these assays will also accommodate OD measurements 
at 37 ºC. Importantly, though, due to the small light path of the 96-well plate, much higher 
spore amounts are needed to achieve an OD600 ~0.5 so that we can monitor sufficient OD 
change during germination. These higher spore concentrations lead to a concominant 
increase in the unidentified amino acid co-germinant receptor concentration(s) which 
would influence EC50 calculations (an increased receptor concentration would lead to an 
increase in the EC50 value). 
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One of the reasons why glycine might be more effective as a co-germinant is 
because of its size. Glycine is the simplest amino acid, which may help with diffusion 
through the spore layers. Importantly, though, size alone cannot explain why glycine 
functions as the best amino acid co-germinant. Since, the next best amino acid co-
germinants were L-alanine, taurine and L-glutamine (for C. difficile UK1) and some of 
these amino acids are larger than L-serine, which functioned as a poorer co-germinant 
(Table 4). These observations also held true for C. difficile M68 spore germination (Table 
5). Though the hierarchical order of co-germinant efficacy was slightly different, L-serine 
was a poorer spore germinant than L-arginine and L-alanine (Table 4). 
Glycine is also important for C. difficile growth because it can be used in Stickland 
reactions to produce energy (113, 129). During Stickland-based metabolism, amino acids 
are oxidatively decarboxlyated or deaminated to produce ATP and NADH (129). In the 
reductive branch, D-proline or glycine are reduced by proline reductase or glycine 
reductase, respectively, to regenerate NAD+ (129). C. difficile spores can use both glycine 
and D-proline as amino acid co-germinants (Table 4). However, in the two C. difficile 
strains tested, glycine was the best co-germinant while D-proline was a poor co-germinant 
(Table 4). An interesting hypothesis is that germinating C. difficile spores may 
preferentially utilize glycine as an energy source during outgrowth of a vegetative cell. In 
a prior publication, D-proline was found to be the preferred amino acid for vegetative 
growth while glycine was less important (113). It would be interesting to test the effects 
of glycine and proline during outgrowth of C. difficile spores. 
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C. difficle UK1 and M68 strains are different ribotypes (UK1 is 027 while M68 is 
017). In these two ribotypes, it was previously reported that the EC50 for TA was similar 
(~3 mM) (80, 90). However, we found that the EC50 values of amino acid co-germinants 
varied between the two strains. We found that the hierarchy of amino acids that functioned 
as co-germinants differed except for glycine (the most efficient), and aspartic acid (the 
least efficient). Interestingly, germination of C. difficile UK1 was more efficient with most 
amino acids than was observed for C. difficile M68 strain with some exceptions (e.g., L-
arginine and D-lysine had EC50 values lower for M68). 
In a previous report, L-methionine, L-serine, L-lysine, L-histidine, and L-aspartic 
acid were not co-germinants for C. difficile spores (74). However, we found that at 37 ºC, 
these amino acids functioned as co-germinants to trigger germination. Previously, C. 
difficile CD630 (ribotype 012) was used to characterize germination in response to 
different amino acid co-germinants. In that study, 12 mM of amino acids was used to test 
amino acids as co-germinants. We found that the EC50 values for some of these amino 
acids to be below the 12 mM concentration used in the prior work. Thus, it is likely that 
12 mM was not sufficient to trigger germination in this study at the lower temperature 
(74). These results support the hypothesis that temperature at which germination is tested 
/ occurs is an important consideration for C. difficile spore germination. 
In our study, there were several amino acids whose EC50 values could not be 
calculated. L-phenylalanine and L-cysteine were previously shown to function as co-
germinants . However, L-cysteine interfered with DPA release assay and L-phenylalanine 
did not dissolve at a concentration necessary for calculating the EC50 value, and, thus, we 
60 
could not determine their EC50 values. Also, we found that L-glutamate is a slow co-
germinant, but we could not determine the EC50 value for the M68 strain (for unknown 
reasons, the kinetic analysis of spore germination with L-glutamate as a co-germinant 
yielded negative EC50 values). 
Consistent with a prior study that analyzed germination at a 12 mM concentration, 
we found L-valine, L-isoleucine and L-leucine were poor germinants, even at the highest 
tested concentration (500 mM) [Table 4]. Although nonpolar, like glycine or alanine, these 
amino acids have branched methyl groups attached to their side chains closer to the alpha 
carbon. We also noticed that negatively charged amino acids, such as glutamic acid and 
aspartic acid, have higher EC50 values, making them poor co-germinants. However, 
positively charged amino acids were better co-germinants even though they have longer 
side chains. 
Even though the D-form of amino acids are not normally recognized as activators 
of germination, we observed that the D-forms of amino acids could function as co-
germinants with TA. However, these forms were weaker germinants compared to the L-
form. We know from a previous report that the C. difficile alanine racemase, Alr2, has 
affinity for and can interconvert both L/D-alanine and L/D-serine (74, 124). Thus, it is 
possible that other racemases could be part of the spore coat and influence the ability of 
D-form amino acids to function as co-germinants. In fact, a prior study by Lawley and 
colleagues that characterized the spore proteome found that a putative proline racemase 
(CD3237) was present (112). 
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An important question is if our findings are physiologically (i.e., in vivo) relevant. 
The concentration of most of the amino acids found in the distal colon are less then 3.5 
mmol / kg. Physiologically, the concentration of alanine is ~0.89 mmol / kg and glycine 
is ~1.79 mmol / kg. The EC50 for glycine is 190 µM for UK1, which is below the glycine 
concentration in the distal colon (83, 130). Interestingly, we found that taurine was a good 
co-germinant for C. difficile spores in both the UK1 (2.5 mM) and M68 isolates (7.7 mM). 
In the gut, taurine is normally found to be conjugated to cholic acid (taurocholic acid, a 
very effective bile acid germinant) (122, 123). In healthy individuals, taurine was found 
to be at 3.53 mmol / kg in the descending colon and 2.89 mmol / kg in the rectum (83). 
This concentration is well within the EC50 range and suggests that glycine and taurine 
could effectively be used as co-germinants in a healthy host (the concentration in an 
antibiotic treated host was not analyzed in the prior study). 
Here, our findings suggest that C. difficile spores can respond to a variety of amino 
acids as co-germinants with taurocholic acid. Interestingly, there appears to be a hierarchy 
in recognition of these amino acids with glycine, alanine and taurine functioning as the 
most efficient co-germinants. To date, the germinant receptor that recognizes the amino 
acid co-germinants has not been identified. Because C. difficile is well-equipped to 
respond to a variety of amino acids as co-germinants, it either uses several different / 
redundant receptors to repond to this variety of germinants, or, as hypothesized previously, 
the yet-to-be-identied receptor is significantly promiscuous (74). 
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CHAPTER IV 
THE REQUIREMENT FOR THE AMINO ACID CO-GERMINANT DURING 
Clostridium difficile SPORE GERMINATION IS INFLUENCED BY 
MUTATIONS IN yabG AND cspA 
In Chapter IV, I have used various techniques to identify the amino acid germinant 
receptor. I successfully demonstrated that CspA is the amino acid germinant receptor 
recognized by various amino acids during germination. Based on my results, I proposed a 
new model for C. difficile spore germination. 
4.1 Introduction 
Clostridioides difficile (formerly Clostridium difficile) (1, 114, 115) is a Gram-
positive, spore-forming pathogenic bacterium, and has become a leading cause of 
nosocomial diarrhea in the United States (7, 86). C. difficile infection (CDI) is commonly 
the result of disruption to the gut microflora caused by antibiotic use (86, 117, 131). Due 
to the broad-spectrum nature of many antibiotics, alterations to the ecology of the colonic 
microbiome results in the loss of the colonization resistance that is provided by the 
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microbiota. Subsequently, patients are treated with other, broad-spectrum, antibiotics 
(e.g., vancomycin or fidaxomicin) which treat the actively growing, toxin-producing, 
vegetative cells (132). Although these antibiotics alleviate the primary symptoms of 
disease, the continued disruption to the colonic microbiome results in frequent CDI 
recurrence. The symptoms of CDI are caused by the actions of two secreted toxins. TcdA 
(an enterotoxin) and TcdB (a cytotoxin) are endocytosed by the colonic epithelium and 
inactivate the Rho-family of small GTPases leading to loss of barrier function and 
inflammation of the colonic epithelium (117). 
Though C. difficile vegetative cells produce the toxins that cause CDI, they are 
strictly anaerobic and only survive short periods of time outside the anaerobic colonic 
environment (133). However, the spores that are produced by the vegetative form are 
critical for transmission between hosts because of their resistance to environmental factors 
such as heat, UV, chemicals and, importantly, oxygen (34, 87, 88, 134, 135). The overall 
architecture of C. difficile spores is conserved among all endospore-forming bacteria. The 
centrally-located core is composed of DNA, RNA, ribosomes and proteins necessary for 
the outgrowth of a vegetative cell, post germination (34, 135). The DNA in the core is 
protected from UV damage by small acid soluble proteins (SASPs) and much of the water 
in the core is replaced by pyridine-2, 6-dicarboxylic acid (dipicolinic acid; DPA), chelated 
with calcium (CaDPA), which provides heat resistance to the spores (31, 34, 135). The 
core is surrounded by an inner membrane composed of phospholipids with minimal 
permeability to small molecules, including water (31). A thin germ-cell-wall layer 
surrounds the inner membrane and becomes the cell wall of the vegetative cell upon 
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outgrowth. A thick layer of specialized peptidoglycan (cortex) surrounds the germ cell 
wall and helps constrain the core against osmolysis (31). Finally, surrounding the cortex 
is the outer membrane which serves as an organization structure / point for the coat layers 
(34, 49, 51, 136). All these features of endospores contribute to ensuring that the spores 
remain metabolically dormant. 
Though dormant, spores still sense their environment for species-specific 
germination-inducing small molecules and, when appropriate germinants are present, 
initiate the process of spore germination. Much of our knowledge of spore germination 
comes from studies in Bacillus subtilis (a model organism for studying spore formation 
and germination). In B. subtilis, and most other endospore-forming bacteria, germination 
is activated upon binding of the germinants to the Ger-type germinant receptors that are 
deposited in or on the inner spore membrane (89, 121). In B. subtilis, this event triggers 
an irreversible process whereby CaDPA is released through a channel composed of the 
SpoVA proteins (137-143). The release of CaDPA is an essential step for the germination 
process because it results in the rehydration of the spore core and permits the eventual 
resumption of metabolic activity. In B. subtilis, the cortex peptidoglycan layer is then 
degraded, and this event can be activated by the CaDPA that is released from the core 
(78). 
In contrast to B. subtilis, C. difficile does not encode orthologues of the Ger-type 
germinant receptors suggesting that C. difficile spore germination is fundamentally 
different than what occurs in most other studied organisms (88). Germination by C. 
difficile spores is triggered in response to certain bile acids in combination with certain 
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amino acids (60, 88, 144). In all identified C. difficile isolates, the cholic acid-derivative, 
taurocholate (TA), is the most efficient bile acid at promoting spore germination, and 
glycine is the most efficient amino acid co-germinant (80, 145, 146). Recently, calcium 
was identified as an important contributor to spore germination, though its role remains 
unclear (77). Calcium may function as a bona fide spore co-germinant, a co-factor for a 
process essential for spore germination and / or as an enhancer for amino acids (77, 134). 
In a screen to identify ethyl methane sulfonate (EMS) generated mutants that could 
not respond to TA as a spore germinant, we identified the germination-specific, subtilisin-
like, pseudoprotease, CspC, as the C. difficile bile acid germinant receptor (61). Prior to 
work performed in C. difficile, the Csp locus was best studied in Clostridium perfringens 
(64, 147-149). C. perfringens encodes three Csp proteases, CspB, CspA, and CspC, that 
are predicted to cleave the inhibitory pro-peptide from proSleC, a spore cortex hydrolase 
that degrades the cortex peptidoglycan, thereby activating the protein (64, 147-149). In C. 
difficile, CspB and CspA are encoded by one ORF and the resulting protein is post-
translationally processed into CspB and CspA and then further processed by the 
sporulation specific protease, YabG (69, 92, 135, 150). CspC is encoded downstream of 
cspBA and is part of the same transcriptional unit. Interestingly, the catalytic residues in 
CspA and CspC are lost, suggesting that only the CspB protein can process proSleC to its 
active, cortex degrading form (61, 92). Although present in the spore, and essential for C. 
difficile spore germination, the CspA pseudoprotease has only been shown to regulate the 
incorporation of CspC into the spore (69, 150). 
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In our working model for spore germination, activation of CspC by TA leads to 
the activation of the CspB protein which cleaves proSleC into its active form. Activated 
SleC degrades cortex and the core releases CaDPA in exchange for water by a 
mechanosensing mechanism (70). Because the receptor with which amino acids interact 
is unknown, we sought to screen for chemically-generated mutants that have altered amino 
acid requirements during spore germination [similar to the strategy used to identify the 
bile acid germinant receptor (61)]. Here, we report that a mutation in yabG gene results in 
strains whose spores no longer respond to or require amino acid co-germinants but respond 
to TA alone as a spore germinant. We hypothesize that the misprocessing of CspBA in the 
yabG mutant leads to this phenotype and provide evidence that short deletions in CspA 
alter the requirements for a co-germinant during spore germination. Our results suggest 
that CspA may be the amino acid co-germinant receptor. 
4.2 Materials and methods 
4.2.1 Growth conditions 
C. difficile strains were grown on BHIS agar medium (Brain heart infusion 
supplemented with 5 g / L yeast extract and 1 g / L L-cysteine) in an anaerobic chamber 
(Model B, Coy Laboratories Grass Lake, MI) at 37 °C (85% N2, 10% H2, and 5% CO2). 
Antibiotics were added as needed (15 µg / mL of thiamphenicol, 10 µg / mL lincomycin, 
and 20 µg / mL uracil). Deletion mutants were selected on C. difficile minimal medium 
(CDMM) supplemented with 5 µg / mL 5-fluoroorotic acid (FOA) and 20 µg / mL uracil. 
Bacillus subtilis was used as a conjugal donor strain to transfer plasmids into C. difficile 
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and was grown on LB medium with 5 µg / mL of tetracycline and 2.5 µg / mL of 
chloramphenicol. Conjugation was performed on TY medium (3% Bacto Trypone, 2% 
yeast extract, and 0.1% thioglycolate) with or without uracil. E. coli DH5α and E. coli 
MB3436 were grown on LB medium supplemented with 20 µg / mL chloramphenicol at 
37 °C. 
4.2.2 Spore purification 
C. difficile spores were purified as described previously (70, 80, 93, 144). Briefly, 
the strains without plasmids were grown on BHIS agar medium while strains with plasmid 
were grown on BHIS agar medium supplemented with 5 µg / mL thiamphenicol and 
allowed to grow for 4 days. Cells from each plate were scraped into 1 mL sterile water 
and incubated at 4 °C overnight. Next, the cells were washed five times with water and 
combined into 2 mL total volume. The washed spores were layered on top of 8 mL of 60% 
sucrose and centrifuged at 4,000 X g for 20 minutes. The supernatant was discarded, and 
the spores were washed five more times with water and incubated at 4 °C until use. 
4.2.3 EMS mutagenesis and phenotype enrichment 
An overnight culture of wild type C. difficile UK1 vegetative cells were diluted to 
an OD600 of 0.05 into two, separate 15 mL falcon tubes containing BHIS liquid and grown 
for 3 - 4 hrs. To one of the cultures, ethyl methane sulfonate (EMS) was added to a final 
concentration of 50 µg / mL; the other culture was untreated for use as a negative control. 
The cultures were grown for 3 hours and then centrifuged at 3,000 X g for 10 min. The 
supernatants were discarded, and pellets were washed two more times with BHIS. After 
the final wash, the pellets were suspended in 40 mL BHIS medium and allowed to recover 
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overnight. The recovered EMS-treated cells were then plated onto 10 - 12 BHIS plates (25 
µL on each plate) to produce spores. Spores were purified from the EMS-treated strain as 
described above. Purified spores were heat activated at 65 °C for 30 minutes before 
enrichment as shown in Figure 10A. The EMS-treated spores were treated for 15 minutes 
with HEPES buffer (50 mM HEPES, 100 mM NaCl, pH 7.5) supplemented with 10 mM 
TA and 10 mM betaine and then washed twice with buffer. Germinated, washed spores 
were plated onto BHIS agar medium for spore formation. This procedure was repeated 
iteratively for 4 – 5 times before isolating candidate strains for phenotypic screening. 
4.2.4 Characterizing mutant phenotypes 
The mutant spores were initially characterized by measuring the CaDPA release 
from germinating spores. Spores were heat activated at 65 °C for 30 minutes and 
suspended in water at an OD600 = 50. The spores were then added to final OD of 0.5 in 
100 µL final volume of HEPES buffer containing 250 µM Tb3+, 10 mM TA and / or 10 
mM betaine in a 96 well plate. The CaDPA release was measured using a SpectraMax M3 
plate reader for 30 minutes at 37 °C with excitation at 270 nm and emission at 545 nm 
with a 420 nm cutoff. 
The phenotype of the yabG mutant (RS08) and cspBA deletion mutants were 
determined by measuring changes to the OD600 and release of DPA. OD600 was monitored 
at 37 °C for 1 – 2 hrs using the plate reader. The spores were added to a final OD of 0.5 
in HEPES buffer supplemented with 30 mM glycine alone or 10 mM TA alone or 10 mM 
TA and 30 mM glycine in 100 µL final volume. CaDPA release was measured as described 
above with spores containing final OD600 of 0.25. 
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4.2.5 DNA sequencing 
High-quality genomic DNA was purified from logarithmically growing C. difficile 
cells (151). Genomic DNA from the EMS-mutant strains and the wild type parent was 
sent for paired end sequencing at Tufts University Genomics Core. Reads were aligned to 
the R20291 genome using DNASTAR software and SNPs determined (DNASTAR, 
Madison, WI). RAW sequence (fastq) reads were uploaded to the NCBI Sequence Read 
Archive as follows (Table 6): C. difficile UK1 parent (SRS3677310), Mutant 20C 
(SRS3677309), Mutant 27E (SRS3677307), Mutant 30A (SRS3677308), Mutant 30C 
(SRS3677311), Mutant 31D (SRS3677312). 
4.2.6 Molecular Biology 
The oligonucleotides used for making the strains and plasmids used in this study 
are listed in Table 9. yabG and sleC mutants were created in the C. difficile R20291 
background by using the TargeTron mutagenesis system. The potential insertion sites for 
targeting the group II intron were found using the Targetronics algorithm (Targetronics, 
LLC.) and a gBlock (Integrated DNA Technologies, San Jose, CA) of the group II intron 
targeted to yabG at the 279th position was ordered (Table 9) and cloned into pJS107 at the 
HinDIII and BsrGI restriction sites using Gibson assembly. The ligation was then 
transformed into E. coli DH5α. The site to engineer a TargeTron insertion in sleC (pCA6) 
was previously described for C. difficile UK1 (93) and the same protocol was used to 
engineer the insertion into R20291. The TargeTron insertion plasmids were isolated from 
E. coli DH5α and transformed into E. coli MB3436 (a recA+ strain) and then into B. subtilis 
(BS49). Conjugation between B. subtilis and C. difficile R20291 was performed on TY-
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agar medium for 24 hrs before plating onto selection plates. Once the plasmid was inserted 
into C. difficile, the colonies were screened for tetracycline-sensitive and thiamphenicol-
resistant colonies and confirmed with PCR. yabG or sleC TargeTron mutants were 
selected by plating the colonies onto BHIS supplemented with lincomycin. Lincomycin-
resistant colonies were tested by PCR and confirmed by sequencing the mutation. yabG 
and sleC TargeTron mutants were renamed as RS08 and RS10, respectively (Table 8). 
A yabG complementing plasmid (pRS97) was created using primers 5' 
XbaI_Prom_YabG and 3' YabG_XhoI to amplify the yabG promoter and yabG coding 
regions and cloned into pJS116. The complementing plasmid was then inserted into C. 
difficile RS08 by conjugation with B. subtilis, as described above. 
To engineer the required site-specific deletions, the pyrE-mediated allelic 
exchange strategy was used with the C. difficile CRG2359 strain (R20291 ∆pyrE). Briefly, 
1 kb upstream and 1 kb downstream fragments that surround the desired mutation in cspBA 
or preprosleC were cloned into pJS165 using primers listed in Table 9. The plasmids were 
inserted into C. difficile CRG2359 strain using B. subtilis conjugation as described above. 
The strains containing the plasmids were then passaged several times to encourage the 
formation of single recombinants before passing onto CDMM-FOA-uracil medium. 
Thiamphenicol-sensitive candidate strains were tested by PCR for the desired mutations 
and confirmed by sequencing for the mutagenized regions. Where indicated, pyrE was 
restored to wild type using pRS107 (Table 7). 
4.2.7 Western blot 
Samples were prepared for CspB, CspA, and CspC western blot by extracting 
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the protein standard, recombinant CspB, SleC and CspC protein were purified using a 
previously described protocol (80). Standard amount of protein or number of spores were 
solubilized in NuPAGE sample buffer (Life Technologies) and heated at 95 °C for 20 
minutes. Equal volume of spore extracts and recombinant CspB, CspC or SleC standard 
proteins were separated by SDS-PAGE. Proteins were then transferred onto low-
fluorescence polyvinylidene difluoride membrane (PVDF) at 30V for 16 hours. The 
membranes were then blocked in 10% skimmed milk in TBS (Tris-buffered saline) and 
washed thrice with TBS containing 0.1% (vol / vol) Tween-20 (TSBT) for 20 minutes 
each at room temperature. The membranes were then incubated with anti-CspB, anti-CspC 
or anti-SleC antibodies for 2 hours and washed with TSBT thrice. For the secondary 
antibody, AlexaFlour 555-labeled donkey anti-rabbit antibody was used to label the 
membranes for 2 hours, in the dark. The membranes were washed again, thrice, with 
TBST, in the dark, and scanned with GE Typhoon Scanner using Cy3 setting, an 
appropriate wavelength for the Alexa Flour 555 fluorophore. The fluorescent bands were 
quantified using ImageQant TL 7.0 image analysis software. Intensity of the extracted 
protein in each blot was compared to the standard curve that was generated from the 
recombinant protein included on each blot. 
To analyze SleC activation, equal number of spores were suspended in HEPES 
buffer supplemented with 30 mM glycine or 10 mM TA or 10 TA and 30 mM glycine and 
incubated at 37 °C for 1 hr to 2 hrs. The samples were then centrifuged at 15,000 X g for 
soluble proteins from 2x109 / mL spores (R20291, yabG::ermB, yabG::ermB pyabG). For
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1 minute and pellets were suspended in NuPAGE sample buffer and heated for 20 min at 
95 °C. The suspension was centrifuged at max rpm for 10 min. The supernatant was 
separated and transferred into new tubes. The samples were stored at -20 °C until use. For 
CspC, CspA and CspB western blots, an equal number of spores were suspended in 
HEPES buffer and boiled to extract the protein and loaded in 10% SDS- PAGE gel. The 
spore extracts were then transferred into nitrocellulose membrane for western blot 
analysis. 
4.2.8 Statistical analysis 
All germination assays were performed in triplicate and data points represent the 
average of three independent experiments. Error bars represent the standard error of the 
mean. A 1-way ANOVA with Tukey’s multiple comparisons test was used to compare the 
quantified protein amounts. For quantification of proteins, each blot was loaded with 5 
standard proteins and three spore samples. 
4.3 Results 
4.3.1 Identifying C. difficile mutants with altered co-germinant requirements 
In order to identify the receptor with which amino acid co-germinants interact, we 
used a strategy that was previously used to identify the bile acid germinant receptor (CspC) 
(61). Although other strategies, such as Tn-seq, could be used to generate random 
mutations, most of these will result in germination null phenotypes and do not permit the 
screening of subtler phenotypes. As shown in Figure 10A, wild type C. difficile UK1 
vegetative cells were exposed to EMS and recovered. Purified spores derived from the 
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mutagenized bacteria were then germinated in buffer supplemented with 10 mM TA and 
10 mM betaine. The structural difference between glycine and betaine is the presence of 
three methyl groups attached to the N-terminus rather than two hydrogen atoms. Because 
betaine is a glycine analog and does not stimulate spore germination when added with TA 
(74), we hypothesized that we could isolate change-of-function mutants that recognize 
betaine as a germinant or those that no longer require glycine as a co-germinant. Spores 
incubated in the presence of buffered TA and betaine were then plated and allowed to form 
spores. Potential mutants were enriched with this strategy 4 - 5 times before isolating 
colonies and screening for phenotypes. Across several mutagenesis experiments, the most 
commonly-observed phenotypes were strains that did not require the co-germinant glycine 
to germinate and germinated in response to taurocholate only (TA-only). As shown in 
Figure 10B, wild type C. difficile UK1 spores required both TA and glycine to stimulate 
the release of CaDPA from the core. However, spores purified from isolates derived from 
separate EMS mutageneses released CaDPA in the presence of TA only (Figure 10C, 10D, 
and 10E). Importantly, though, these mutants still responded to glycine, the germination 
efficiency/rate increased upon glycine addition. To identify the mutation(s) that caused 
this phenotype, five different mutant strains (isolated from 4 independent EMS 
mutageneses) and a wild-type control were sent for genome re-sequencing. Surprisingly, 
when the sequences of the mutant strains were compared to the sequence of the wild-type 
parent, we identified SNPs common to all 5 mutants in the coding region or the promoter 
region of yabG, a sporulation-specific protease (Table 6). 
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Figure 10. EMS mutagenesis generates C. difficile strains with altered requirements 
for the amino acid co-germinant. (A) Schematic of the EMS mutagenesis strategy where 
(1) C. difficile UK1 vegetative cells were treated with EMS, (2) EMS mutagenized cells 
were recovered and allowed to form spores, (3) purified spores were suspended for 15 
minutes in germination buffer supplemented with 10 mM TA and 10 mM betaine and then 
washed twice with buffer alone, (4) germinated spores were plated onto BHIS agar 
medium to permit colony formation, (5) strains were enriched by exposure TA and 
betaine, iteratively, 4 – 5 times, and (6) spores from the mutant strains were isolated for 
screening. The germination phenotype of wild type C. difficile UK1 (B) and mutant spores 
(C – E) were screened by measuring CaDPA release in presence of (●) 30 mM glycine, 
(■) 10 mM TA or (▲) 10 mM TA and 30 mM glycine. The data points represent the data 
from a single germination experiment. Germination plots performed in triplicate yielded 
error bars that obscure the data. For transparency, all germination plots can be found in 
Figure S5. 
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Table 6 Location of the mutations in yabG found in the EMS mutant strains 
Mutant Reference Coding region Promoter region 
20C (Mutant1) 4048886 G-T(Ala46Asp) 
27E (Mutant 2) 4049063 G-42A 
30A (Mutant 3) 4048565 G-A (Pro153Leu) 
30C 4048913 C –T (Gly37Glu) 
31D 4049030 C-8T 
Nucleotide positions in the promoter region are mapped from the ATG of the open 
reading frame (the yabG transcriptional start site is unknown) 
4.3.2 Characterizing the function of yabG 
To confirm that the TA-only phenotype is caused by a mutation in yabG, we 
inserted a group II intron into the yabG gene of C. difficile R20291 using TargeTron 
technology. Germination of the C. difficile yabG::ermB mutant (RS08) spores was 
compared to wild type using both OD600 and CaDPA release assays (Figure 11). As shown 
in Figure 11A, wild-type C. difficile R20291 spores required both TA and glycine in order 
to germinate. Interestingly, the RS08 mutant spores germinated in response to TA-only 
and this germination phenotype was not enhanced by the addition of glycine (in contrast 
to the phenotype of the EMS-mutant spores) (Figure 11B). We also tested L-alanine as a 
co-germinant instead of glycine (Figure S6), however, the spores did not show any 
enhancement in germination with the addition of L-alanine and germinated only in 
response to TA alone. When the mutation was complemented in trans by expression of 
yabG from a plasmid (pRS97), the spores again recognized glycine as a germinant (Figure 
11C). The TA-only phenotype in the mutant spores was also 
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Figure 11. A mutation in C. difficile yabG results in spores that do not respond to 
amino acids as co-germinants. Spores derived from C. difficile R20291, yabG::ermB 
and yabG::ermB pyabG strains were suspended in buffer supplemented with (●) 30 mM 
glycine or (■) 10 mM TA or (▲) 10 mM TA and 30 mM glycine. Germination was 
monitored at OD600 (A, B, C) or by the release of CaDPA in presence of 250 µM Tb
3+ (D, 
E, F), respectively. Data points represent the averages from three, independent 
experiments and error bars represent the standard error of the mean. (G) Equal numbers 
of spores were extracted with NuPAGE buffer and separated by SDS-PAGE followed by 
immunoblotting with antisera specific for each listed protein. (H) Equal numbers of spores 
were incubated in 30 mM glycine or 10 mM TA or 10 mM TA and 30 mM glycine. Spores 
were then extracted and separated by SDS-PAGE. SleC activation was analyzed using 
antisera specific for the SleC protein (the SleC antibody detects the preproSleC, proSleC 
and activated SleC forms). 
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confirmed by CaDPA release and compared to spores from both wild type and the 
complemented strain (Figure 11D, 11E, 11F). 
In prior work, a yabG mutant strain accumulated unprocessed CspBA into spores 
(69). To confirm that the generated yabG mutant results in the accumulation of CspBA, 
we extracted spores derived from R20291, RS08 and the complemented strain and 
separated the extracted protein by SDS-PAGE. The separated protein was then detected 
using immunoblotting with CspB-specific antisera (Figure 11G). Although the blot 
showed that some CspBA is remaining in both the wild type and complemented strains, 
the yabG mutant had mostly the unprocessed, CspBA form. Similarly, the CspA western 
blot showed that the yabG mutant had both the CspBA and CspA forms. The mutation in 
yabG did not appear to affect CspC incorporation into the spores although these results 
are not quantitative. 
YabG also was shown to process preproSleC into proSleC (69). Indeed, whereas 
the wild-type and complemented strains incorporated into spores the processed, proSleC, 
form, only preproSleC was incorporated into the RS08 strain (Figure 11H). When tested 
for the processing of SleC during germination, the wild-type and the complemented strains 
required both TA and glycine to activate SleC. However, C. difficile RS08 activated SleC 
in response to TA alone. These results confirm the TA-only phenotype observed in Figures 
11B and 11E and suggest that a protein that is not processed in the yabG mutant strain is 
involved in germinant recognition or regulating the germinant specificity. 
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4.3.3 Quantifying levels of CspB, CspC and SleC in spores from various strains 
Because YabG is a sporulation specific protease, it is possible that the deletion of 
this protease might alter the amount of germination related proteins (e.g., CspB, CspC, 
CspA or SleC) that are incorporated in the spore thereby providing the observed phenotype 
(i.e., increasing the abundance of the germinant receptors could lead to an increase in 
germinant sensitivity and loss of regulation). Using the previously described method to 
quantify the protein levels in C. difficile spores (80), we quantified the abundance of CspB 
(and CspBA), CspC and SleC in C. difficile RS08 (yabG::ermB) and compared them with 
the abundances in the wild-type and complemented strains (Figure 12). 
Introducing the yabG complementing plasmid resulted in significantly increased 
incorporation of proSleC and CspC into spores compared to the RS08 strain (Figure 12A; 
only the preproSleC form is incorporated into the RS08 strain) or the wild-type strain 
(Figure 12B), respectively. There were no statistical differences in the abundance of SleC 
or CspC between the wild-type and mutant strains. Importantly, there was a statistical 
difference in the abundance of CspB in all pair-wise comparisons of the wild type and 
complemented strain (there was no quantifiable CspB protein in spores derived from the 
RS08 strain; Figure 12C). Finally, spores derived from the RS08 strain had significantly 
more CspBA incorporated than did the wild-type or the complemented strains (Figure 
12D). Because spores derived from the complemented strain had increased abundances of 
proSleC (Figure 12A), CspC (Figure 12B), and CspB (Figure 12C), but did not produce a 
TA-only phenotype, this suggests that increased abundance of these proteins is not reason 
for the observed TA-only phenotype in the yabG mutant strain. Importantly, though, 
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Figure 12. Comparing the abundance of CspB, CspC and SleC in C. difficile spores. 
2 x 109 spores purified from C. difficile R20291, the yabG mutant and complemented 
strains and were extracted with NuPAGE buffer. Samples were separated by SDS-PAGE, 
transferred to low fluorescence PVDF membranes and blotted with antisera specific to the 
indicated proteins. The primary antibody was detected with a fluorescently conjugated 
secondary antibody and quantified as described in materials and methods. Quantified 
proteins are expressed as molecules / spore and are represented in a bar graph form. (A) 
SleC, (B) CspC, (C) CspB and (D) CspBA. The data presented represent the averages from 
three independent experiments and error bars represent the standard error of the mean. 
Statistical significance was determined using a 1-way ANOVA with Tukey’s multiple 
comparisons test (* p < 0.05; ** p < 0.01). yabG::ermB only incorporates the preproSleC 
form. 
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the yabG mutant accumulated much more CspBA into spores than did the wild-type or the 
complemented mutant strains (Figure 12D) and only accumulated the preproSleC form 
(Figure 12H). Therefore, we hypothesized that the presence of full-length CspBA and / or 
preproSleC could contribute to the observed TA-only phenotype. 
4.3.4 Deletions in the cspBA coding sequence lead to the observed TA-only 
phenotype 
Because CspB and CspC are already known to be involved in regulating C. difficile 
spore germination (61, 69, 92, 93, 150), we chose to first focus on the processing of CspBA 
by YabG. In prior work by Kevorkian et. al. (69), the CspBA processing site was 
hypothesized to occur at or near amino acid 548. To test this hypothesis, we deleted from 
the C. difficile CRG2359 (C. difficile R20291 ΔpyrE) chromosome 12 aa between CspB 
and CspA (cspBAΔ548-560) using pyrE-mediated allelic exchange. After confirmation of the 
engineered mutation in the CRG2359 genome, the pyrE gene was restored, and 
germination of the resulting strain was compared to pyrE-restored CRG2359 strain (C. 
difficile RS19; Figure S7A). We found that the CspBA∆548-560 allele did not have any effect 
on germination (Figure S7B) and it was the same as the germination found in the pyrE 
restored, RS19 strain. 
Next, to determine if deletions in the coding region in or between cspB and cspA 
affect spore germination, we deleted various regions within the cspBA gene in the 
CRG2359 strain (Figure 13A). The results of the germination phenotype in various 
deletions are shown in Figure 13. Deletion of 26 codons from the C-terminus of cspB 
(RS20; CspBA∆522-548) did not affect spore germination (Figure 13C) when compared to 
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Figure 13. The N-terminus of C. difficile CspA is important for regulating 
germination in response to glycine. (A) Graphical representation of the various deletions 
introduced into cspBA compared to the parental, CRG2359; R20291ΔpyrE strain. Spore 
germination of the indicated strain was monitored at OD600 in buffer supplemented with 
(●) 30 mM glycine or (■) 10 mM TA or (▲) 10 mM TA and 30 mM glycine. (B) 
CRG2359, (C) RS20 (cspBAΔ522-548), (D) RS21 (cspBAΔ560-586), (E) RS23 (cspBAΔ542-567), 
(F) RS24 (cspBAΔ537-571) and (G) RS27 (cspBAΔ560-610). 
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the wild-type CRG2359 strain (Figure 13B). These results suggest that the C-terminus of 
CspB is not involved in generating the TA-only phenotype. Interestingly, deletion of 26 
codons at the N-terminus of cspA (RS21; CspBA∆560-586) resulted in spores that germinated 
in response to TA-only, after 60 minutes of incubation in the germination solution (Figure 
13D). Though deletion of 25 codons in between the cspB and cspA coding sequences did 
not result in a TA-only phenotype (RS23; CspBA∆542-567) (Figure 13E), extending the 
deleted region by another 9 codons into the surrounding region (RS24; CspBA∆537-571) 
resulted in spores that germinated in response to TA-only, again after 60 minutes of 
incubation (Figure 13E). Importantly, the spores derived from the RS21 and RS24 strains 
still respond to glycine as co-germinant, despite also germinating in response to TA-only. 
Because the TA-only phenotype appeared to be enhanced as more cspA was deleted (RS21 
to the RS24 strain), we predicted that a larger deletion might result in a phenotype similar 
to that observed in the yabG mutant (which does not recognize glycine as a co-germinant). 
We found that when 50 codons were deleted from the N-terminus of CspA (RS27) the 
spores no longer germinated (Figure 13F). These results were confirmed by analyzing the 
release of CaDPA from the germinating spores (Figure S8). 
During construction of the deletion strains, we encountered significant difficulties 
in restoring the pyrE allele to wild type. To circumvent this obstacle, and to understand if 
C. difficile spore germination is affected by the pyrE deletion, we restored pyrE in the 
RS21 strain (CspBA∆560-586, pyrE
+; RS26) and compared with the RS19 strain (CRG2359 
with restored pyrE). As shown in Figure S9A, C. difficile RS19 required both TA and 
glycine to germinate but the RS26 strain germinated in response to TA-only (Figure S9B). 
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These results were confirmed by analyzing the release of CaDPA from the spore (Figure 
S9C and S9D). Finally, we analyzed the activation of proSleC to SleC in response to TA 
alone. Only the RS26 strain cleaved proSleC in response to TA alone (Figure S9E). These 
observations are identical to the observations made for the RS21 strain (Figure 13 and 
Figure S8) and indicate that the pyrE allele does not influence C. difficile spore 
germination in the context of these studies. 
Figure 14. Comparing the effects of mutations in C. difficile cspBA on the 
incorporation and processing of CspB, CspA, CspC and proSleC. Spores derived from 
the indicated strains were extracted and separated as described in Figure 11. (A) SleC 
activation was measured in buffer supplemented with 30 mM glycine or 10 mM TA or 
both 10 mM TA and 30 mM glycine for 2 hours at 37 °C and (B) CspB, CspA, and CspC 
were detected as described in Figure 11 (*full length CspBA, ** alternative processing of 
CspA). 
To confirm our observations that the strains germinated in response to TA alone, 
we analyzed by western blot the activation of SleC (Figure 14A). SleC activation in 
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response to 10 mM TA only occurred in RS21 and RS24 while RS27 did not germinate in 
response to TA and glycine. The CspB western blot showed that CspBA was processed to 
CspB and CspA in all of the mutants, compared to wild type (Figure 14B). The CspC 
western blot did not reveal any differences between the wild type and mutant strains, 
except for the RS27 strain where no CspC was detected. 
4.3.5 Deletion of a hypothesized YabG cleavage site in CspA and preproSleC results 
in the TA-only phenotype 
The data presented above suggests that the N-terminus of CspA is important for 
regulating spore germination. We had hypothesized that this region is processed by YabG 
but all the generated cspA alleles generated a protein that was processed into the CspB and 
CspA forms. One way to identify the YabG processing site in CspA is by pulldown of 
CspA from the spore extract and sequencing the CspA protein using mass spectrometry. 
Unfortunately, the CspA antibody was unable to immunoprecipitate CspA from the spores 
due to the quality of the antibody. However, we predicted that the YabG processing site 
in CspBA might be conserved in preproSleC. Instead of immunoprecipitating CspA, we 
immunoprecipitated proSleC from spore extracts derived from wild-type spores and sleC 
mutant spores (as a negative control) (Figure 15A). Using the sample from the proSleC 
pull down, we identified fragments by mass spectrometry of trypsin-digested proSleC 
(Figure 15B). In this experiment, the most N-terminal fragment identified began with 
glutamine followed by serine (an SRQS sequence). When we compared this sequence to 
the protein sequence in CspA, we found that within the N-terminus of CspA there was a 
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SRQS amino acid sequence that was encompassed within the deletions found in the RS21 
strain (a strain that generated a TA-only phenotype). 
 
 
Figure 15. Immunoprecipitation of proSleC from C. difficile spores reveals a 
potential YabG cleavage sequence. (A) Spores derived from C. difficile R20291 (WT) 
and C. difficile RS10 (sleC::ermB) were disrupted by bead-beating and then proSleC was 
immunoprecipitated using SleC-specific antisera. Samples were separated by SDS-PAGE 
gel and stained with Commassie blue. The band corresponding to proSleC was excised 
from the gel and analyzed by peptide mass finger printing. (B) The sequence of preproSleC 
is listed. Yellow highlighted regions correspond to fragments that were detected by mass 
spectrometry and amino acids highlighted in green indicate amino acids that are modified 
in the MS analysis (i.e., oxidated, deaminated, acetylated or ammonia loss).  
 
 
We deleted the nucleic acid sequence that encodes this SRQS motif in sleC, cspBA, 
or in both genes (Figure 16A). Surprisingly, the deletion of the SRQS site in CspA resulted 
in spores that germinated in response to TA-only within 40 minutes after germinant 
addition (Figure 16B). However, deletion of the SRQS motif within preproSleC did not 
affect spore germination (Figure 16C). When these two deletions were combined in the 
same strain, the spores had a TA-only phenotype similar to that of spores with a deletion 
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in CspA alone (Figure 16D and 16A). Next, we confirmed these phenotypes by analyzing 
the release of CaDPA from the spore (Figure S10). Again, only when the cspA∆SRQS allele 
was incorporated into spores did the resulting strains release CaDPA in response to TA-
only (Figure S10A and S10C); sleC∆SRQS spores required both TA and glycine to release 
CaDPA (Figure S10B). 
We next analyzed the activation of SleC for these deletions. proSleC was activated 
in response to TA-only phenotype in the RS29 (cspA∆SRQS) and the RS31 (cspA∆SRQS + 
sleC∆SRQS) strains but not in the RS30 (sleC∆SRQS) strain (Figure 16E). Interestingly, we 
also noticed that deletion of the SRQS sequence in the RS30 and RS31 strains did not 
result in the incorporation of full length preproSleC into the spores. Rather, preproSleC 
was still processed to a size consistent with a proSleC form, potentially suggesting that 
the SRQS sequence is not the YabG cleavage site or the presence of an alternative YabG 
processing site in preproSleC. There was no difference in the CspB, CspC and CspA 
incorporation in these SRQS deletion mutants compared to wild type (CRS2359; Figure 
16F). Regardless, our results indicate that due to mis-processing of CspBA, or alterations 
within the cspA sequence, spores lose the requirement for an amino acid co-germinant 
during spore germination. 
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Figure 16. Deletion of the hypothesized YabG cleavage site in CspA results in a TA-
only phenotype. (A) Graphical representation of the various deletions introduced into 
cspBA compared to the parental, CRG2359; R20291ΔpyrE strain. Spore germination of 
the indicated strain was monitored at OD600 in buffer supplemented with (●) 30 mM 
glycine or (■) 10 mM TA or (▲) 10 mM TA and 30 mM glycine. (B) RS29 (cspAΔSRQS), 
(C) RS30 (sleCΔSRQS), (D) RS31 (cspAΔSRQS, sleCΔSRQS). (E) Spores derived from the 
indicated strains were extracted and separated as described in Figure 11 and SleC 
activation was measured in buffer supplemented with 30 mM glycine or 10 mM TA or 
both 10 mM TA and 30 mM glycine for 2 hours at 37 °C. (F) CspB, CspA, and CspC were 
detected as described in Figure 11 (*full length CspBA, ** alternative processing of 
CspA). 
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4.4 Discussion 
Previous studies on C. difficile spore germination have hypothesized the presence 
of an amino acid co-germinant receptor. We used EMS mutagenesis to screen for C. 
difficile mutants whose spores recognize betaine as a germinant. Excitingly, we isolated 
mutants that did not require an amino acid as a co-germinant, and these EMS-mutants 
germinated in response to TA-only. However, these mutants still recognized glycine as a 
co-germinant; the rate of germination increased upon the addition of glycine to the 
germination solution. Sequencing of these strains revealed common mutations in the yabG 
coding region or promoter region (Table 6). Thus, to confirm the TA-only phenotype 
observed in the EMS-generated mutants is due to the yabG allele, we created a TargeTron 
mutation in yabG of C. difficile R20291. In contrast to the EMS-generated mutants, the 
yabG mutant spores did not recognize glycine as a co-germinant (Figure 10C, 10D, 10E), 
and germinated in response to TA-only (Figure 11B, 11C). These phenotypes could be 
complemented by expressing yabG in trans from a plasmid. Oddly, we noticed that spores 
derived from the complemented strain released CaDPA in response to TA alone, but this 
was not observed when germination was measured at OD600 (Figure 11F vs. 11C). We 
further analyzed this observation and found that the supposed CaDPA release observed in 
the complemented strain in the presence of TA alone was due the presence of Tb3+ in the 
assay (Tb3+ is absent from the germination solution in the OD600 assay) (Chapter V).  
To understand if spores derived from the yabG mutant recognized other amino 
acids as co-germinants, we tested L-alanine. L-alanine is the second-best co-germinant 
during C. difficile spore germination with an EC50 value of 5 mM (144). Because C. 
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difficile RS08 (yabG::ermB) spores did not respond to glycine or L-alanine (Figure S6), 
these results suggest that the protein(s) YabG processes is / are responsible for recognition 
of the various amino acids used as co-germinant(s). It is unclear if all of the amino acid 
co-germinants are recognized by a single protein or if each co-germinant / groups of co-
germinants are recognized by unique proteins. However, our results suggest that glycine 
and other amino acids that trigger germination are recognized by a protein, or a set of 
proteins, that is processed by YabG. 
YabG has been mostly studied in B. subtilis. In B. subtilis YabG is a sporulation-
specific protease, and a yabG mutation causes alterations in the coat proteins of B. subtilis 
spores. The orthologues of most B. subtilis YabG target proteins are absent in C. difficile 
(e.g., CotT, YeeK, YxeE, CotF, YrbA) (67, 68, 91). In a previous report, YabG was shown 
to process CspBA and preproSleC during C. difficile sporulation (69). However, 
germination was not significantly altered in the mutant spores compared to wild type 
spores (germination efficiency decreased from 1 to 0.8 in mutants) (69). Importantly, 
though, germination efficiency was only tested on BHIS-TA agar medium and not in the 
presence of TA alone (69). 
In prior work by Kevorkian et. al. (69), the authors suggested that the CspBA 
processing site is near-amino acid 548 and is encoded by a linker DNA sequence between 
cspB and cspA. To test this, we used allelic exchange to delete the codons encoding amino 
acids 542-567 regions in cspBA (RS23). When the germination phenotype of the RS23 
strain was compared with CRG2359, we did not observe a TA-only phenotype (Figure 
13A and 13E) and, importantly, CspBA was still efficiently processed (Figure 14). These 
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results suggest that the predicted 548-560 region as a processing site by YabG is not 
accurate, or that when the YabG processing site is removed, YabG cleaves the CspBA 
protein at an alternate site. 
Unlike spores derived from the yabG mutant, which did not recognize amino acids 
as co-germinants, the deletions that were engineered in the N-terminus in CspA [e.g., 
CspBA∆560-586 (RS21) or CspBA∆SRQS (RS29)] still responded to glycine as a co-
germinant. In order to recapitulate the yabG mutant phenotype, we hypothesized that 
deletion of a larger portion in the N-terminus of CspA might result in a CspA allele that 
loses the recognition of amino acids as co-germinants. When 50 codons were deleted from 
the region of CspA encoding the N-terminus (CspBA∆560-610; RS27), the spores no longer 
germinated (Figure 13G) and no SleC was activated in any of the tested conditions (Figure 
14). Moreover, we did not observe functional CspA in the spores derived from the RS27 
(although there was a band corresponding to unprocessed CspA similar to what was 
observed in the other deletion and wild-type strains). Prior work on CspA demonstrated 
that deletion of CspA results in spores that do not incorporate CspC (69, 150). Here, we 
found that the 50 amino acids at N-terminus of CspA are important for the incorporation 
of CspC into spores, probably because CspA is non-functional without the N-terminal 
domain or the mutant lacks a secretion signal that directs the processed CspA into the 
spore. 
 Using immunoprecipitation and mass spectrometry of the immunoprecipitated 
protein, we identified four amino acids in SleC with identity in CspBA. When this 
sequence was deleted from CspA (cspBA∆580-584), we observed a TA-only phenotype in 
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the spores suggesting that the SRQS region might be important for CspA activity. Both 
RS21 (cspBA∆560-586) and RS24 (cspBA∆537-571) strains generated spores with TA-only 
phenotypes similar to the SRQS deletion in CspA (RS29; cspBA∆580-584). However, only 
the RS21 strain has the deletion of SRQS region while the SRQS motif is still present in 
the RS24 strain. Importantly, the SRQS deletion in preproSleC resulted in spores with no 
TA-only phenotype and the western blot analysis (Figure 16) showed that deletion of the 
SRQS site in preproSleC resulted in incorporation of the processed, proSleC, into the 
spore instead of preproSleC form. This indicates that the SRQS sequence is not the YabG 
processing site in preproSleC (and, potentially CspBA), or that the deletion of the SRQS 
sequence results in YabG shifting its processing site in preproSleC to a region near the 
SRQS sequence. Further experiments are required to identify the YabG cleavage sites in 
spore proteins and how this processing is affected when its recognition site is deleted. 
In a recent review on C. difficile spore germination (134), the authors build upon 
a hypothesized model for spore germination and propose a new, “lock and key” model for 
C. difficile spore germination. In the first model, the germinosome complex composed of 
CspC, CspA, CspB, and proSleC are anchored to the outer spore membrane by GerS (a 
lipoprotein that is required for spore germination (71) - see below) (88, 134). Upon binding 
of a germinant (TA with glycine or Ca2+), CspC and CspA are released from this 
germinosome complex and CspB becomes free to activate proSleC to degrade the cortex. 
Subsequently, CaDPA is released from the spore core by a mechanosensing mechanism 
(70, 140). In the second model, CspA and CspC are localized in the coat layer, where TA 
can bind to CspC. Activation of CspC leads to the transport of glycine and Ca2+ through 
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the outer membrane, by an unknown protein, to the cortex where CspB is held inactive in 
a complex with GerS and proSleC. In the absence of calcium, glycine is transported to the 
inner membrane where it activates the release of Ca2+ from the core through another 
unknown process. The released Ca2+ traffics to CspB to activate its protease activity. In 
the presence of calcium and glycine, both are transported in and Ca2+ activates CspB. 
When glycine and calcium bind to CspB, CspB can activate proSleC to degrade the cortex 
(134). 
 
 
 
Figure 17. Model for C. difficile spore germination. In our working model for C. 
difficile spore germination, CspB protease activity is inhibited by two pseudoproteases, 
CspC (the bile acid germinant receptor) and CspA (the amino acid germinant receptor; 
this study). Interaction of CspC with cholic acid derivatives (60) and the interaction of 
CspA with amino acids (124, 144) results in these two proteins disassociating from CspB. 
Subsequently, CspB cleaves the inhibitory pro-domain from proSleC thereby activating 
SleC’s cortex degrading activity. 
 
 
Our results support the first model whereby CspB, CspA, and CspC are in a 
germinosome complex – similar to the germinosome complex found in B. subtilis (152). 
Recent studies on GerS have shown that GerS likely does not form a complex with other 
germination proteins (71, 72). Rather, it is required to generate cortex-specific 
modifications in the spore and thus, important for germination of the spore because the 
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SleC cortex lytic enzyme depends on cortex-specific modifications to degrade the cortex 
layer efficiently (72). Based upon prior work from our lab, proSleC is unlikely to be part 
of this complex because SleC is three to four times more abundant than CspB or CspC, 
depending upon the strain analyzed (80). 
The processing of CspBA depends on the YabG protease and yabG-mutant spores 
incorporate mostly the full length CspBA protein. These spores do not recognize amino 
acids as co-germinants and germinate in response to TA-only (Figure 11B). We 
hypothesize CspC (functioning as the bile acid germinant receptor) and CspA (functioning 
as the amino acid co-germinant receptor) inhibit CspB activity within dormant spores 
(Figure 17). These two pseudoproteases would regulate the activity of CspB so that it does 
not prematurely activate proSleC, potentially similar to how other pseudoproteases / 
pseudokinases regulate activity of their cognate proteins (153-157). Because yabG mutant 
spores package full length CspBA, where CspA is tethered to CspB, CspC alone prevents 
CspB from cleaving proSleC into its active form, and TA might dislodge CspC from CspB 
(this is consistent with our prior publication that indicates that CspC may have an 
inhibitory activity during spore germination (80)). Moreover, our data suggest that the N-
terminus of CspA might be important for formation of this hypothesized complex with 
CspC and / or CspB. When portions of the CspA N-terminus are deleted, the binding of 
CspA to the complex might become unstable causing CspA to randomly disassociate from 
the complex. This would result in TA alone stimulating germination by disassociating 
CspC from CspB. Once CspB is free from the complex, it could then activate many 
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proSleC proteins to maximize the germination process. Further work is needed to test the 
biochemical implications of this hypothesis. 
Table 7 Plasmid list with primer pairs to make the plasmids 
Plasmid Description Oligonucleotides 
used (Table 9) 
Referen
ce 
pRS92 
yabG G-block cloned into Zero blunt 813 This 
study 
pRS93 Plasmid to make TT insertion in yabG ” 
pRS97 yabG Complementing plasmid 906/907, 924/925 ” 
pCA6 Plasmid to make TT insertion in sleC (93) 
pMTLYN4 
Plasmid to make deletion in C. difficile using allelic 
exchange 
(158) 
pJS107 TargeTron vector (61) 
pJS116 Empty vector (61) 
pJS165 
Tn916Ori cloned into pMTLYN4 to use B. subtilis 
conjugation for gene insertion 
207, 208 This 
study 
pRS110 
pJS116 with ∆542-567 in CspBA 578/1232, 
1233/1056 
” 
pRS111 
pJS116 with ∆537-571 in CspBA 578/1234, 
1235/1056 
” 
pRS112 
pJS116 with ∆560-586 in CspBA 578/1236, 
1237/1056 
” 
pRS113 
pJS116 with ∆522-548 in CspBA 578/1238, 
1239/1056 
” 
pRS114 
pJS165 with 1Kb upstream and 1Kb downstream 
od ∆542-567 in CspBA  
1160, 1163 ” 
pRS115 
Plasmid to make ∆537-571 in CspBA cloned into 
pJS165 
1160, 1163 ” 
pRS116 
Plasmid to make ∆560-586 in CspBA cloned into 
pJS165 
1160, 1163 ” 
pRS117 
Plasmid to make ∆522-548 in CspBA cloned into 
pJS165 
1160, 1163 ” 
pMTLYN2C Plasmid to restore pyrE (158) 
pRS107 
Tn916Ori cloned into pMTLYN2C to use Bacillus 
subtilis for restoring pyrE 
207, 208 This 
study 
pRS118 
Plasmid to make ∆560-610 deletion in CspA 1160/1287, 
1163/1288 
” 
pRS120 
Plasmid to make SRQS deletion in CspA 1160/1329, 
1163/1330 
” 
pRS121 
Plasmid to make SRQS deletion in preproSleC 1361/1362, 
1363/1364 
” 
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Table 8 Strain list 
C. difficile 
Strain 
Description Plasmids used 
Table 7  
Reference 
UK1 Wild type, ribotype 027 (103) 
R20291 Wild type, ribotype 027 (159) 
CRG2359 R20291 ΔpyrE (158) 
RS08 yabG::ermB in R20291 background pRS93 This study 
RS10 sleC::ermB in R20291 background pCA6 ” 
RS19 CRG2359 with restored pyrE pRS107 ” 
RS20 CRG2359 with ∆522-548 deletion in CspB pRS117 ” 
RS21 CRG2359 with ∆560-586 deletion in CspA pRS116 ” 
RS23 CRG2359 with ∆542-567 in CspBA pRS114 ” 
RS24 CRG2359 with ∆537-571 in CspBA pRS115 ” 
RS26 RS21 with restored pyrE pRS107 ” 
RS27 CRG2359 with ∆560-610 in CspA pRS118 ” 
RS29 ∆SRQS (∆580-584) in CspA pRS120 ” 
RS30 ∆SRQS (∆117-121) in preproSleC pRS121 ” 
RS31 ∆SRQS in CspA and preproSleC pRS120, pRS121 ” 
Other 
Strains 
E. coli 
DH5α 
Cloning vector (160) 
E. coli 
BL21(DE3) 
Expression vector (161) 
E. coli 
MB3436 
recA+ E. coli strain Gift from 
Dr. Michael 
Benedik 
B. subtilis 
Bs49 
Tn916 donor strain, TetR (162) 
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Table 9 Oligonucleotides used in Chapter IV 
Primer # Name of primer Primer Sequence (5’ to 3’) 
156 5' tcdB TTACATTTTGTTTGGATTGGAGGTC 
157 3' tcdB AGCAGCTAAATTCCACCTTTCTACC 
160 5' sleC ATGCAAGATGGTTTCTTAACAGTAAGC 
161 3' sleC TTAAATTAAAGGATTTAAAGAAGCTATTC 
173 5' catP 3 ATGGTATTTGAAAAAATTGATAAAAATAG 
174 3' catP 2 TTAACTATTTATCAATTCCTGCAATTCG 
207 5'Tn916ApaI AA GGGCCC TAA CAT CTT CTA TTT TTC CCA AAT CC 
208 3'Tn916ApaI AA GGGCCC C960 
578 5'pJS116_cspBA 2 CGAATTCGAGCTCGGTACCCGGGGATCCTCTAGAAAAACTATAAAGTTAT
AATTGTTGGAGATGCT 
813 yabG (279s) gBlock TTCCCCTCTAGAAAAAAGCTTATAATTATCCTTAGTTCCCAAACTTGTGCG
CCCAGATAGGGTGTTAAGTCAAGTAGTTTAAGGTACTACTCTGTAAGATA
ACACAGAAAACAGCCAACCTAACCGAAAAGCGAAAGCTGATACGGGAAC
AGAGCACGGTTGGAAAGCGATGAGTTACCTAAAGACAATCGGGTACGAC
TGAGTCGCAATGTTAATCAGATATAAGGTATAAGTTGTGTTTACTGAACG
CAAGTTTCTAATTTCGATTGGAACTCGATAGAGGAAAGTGTCTGAAACCT
CTAGTACAAAGAAAGGTAAGTTATGAAGTTTGACTTATCTGTTATCACCA
CATTTGTACAATCTG 
906 5' XbaI_Prom_YabG GATCCTCTAGAGAAATGTTTTTTTGACATTAG 
907 3' YabG_XhoI GCCTCGAGCTAATGTAATATTGTTTTTGGC 
924 5' pJS116_XbaI_YAbG 
TTCGAGCTCGGTACCCGGGGATCCTCTAGAGAAATGTTTTTTTGACATTAG
G 
925 3' YabG_XhoI_pJS116 
GTGCCAAGCTTGCATGTCTGCAGGCCTCGAGCTAATGTAATATTGTTTTTG
GC 
1056 3' CspC_pJS116 CAAGCTTGCATGTCTGCAGGCCTCGAGTTATCTATAGAGTATTTGCTATCT
GTTGAAT 
1084 5' pyrE 2 GTCCAGTGTTCTGGGGAG 
1085 3 'pyrE 2 AAAATTTACATTTTTTAAGTAACACTATAAATAATTAAGTTTTTA 
1160 5' YN4_1Kb UP_CspBdelA TTCGAGCTCGGTACCCGGGGATCCTCTAGAAAATATAAGTTATGGAAGTA
ATGAA 
1163 3' 1Kb DN_cspBdelA_YN4 TGCCAAGCTTGCATGTCTGCAGGCCTCGAGCCAAAGTTCTAATGATAATT
CTT 
1232 3' 1kb UP cspBA_75nt CTTATATAAATTTCATTCTCTAAGTCATTATATCCAATATCCTCCGTT 
1233 5' 1Kb DN cspBA_75nt 
AAGATTTAGAAACGGAGGATATTGGATATAATGACTTAGAGAATGAAATT
TAT 
1234 3' 1Kb UP_cspBA_102nt 
ACTTGCATTTTTACTTATATAAATTTCATTCGTTTCTAAATCTTGATTTATA
CTA 
1235 5' 1Kb DN_cspBA_102nt 
CTATCTAGTATAAATCAAGATTTAGAAACGAATGAAATTTATATAAGTAA
AAATGC 
1236 3' 1Kb UP_cspA_78nt 
GGGAGTATGGACTACATCTATTCCTGATAGATCTATAAACTTATACCTATT
TTCCTC 
1237 5' 1Kb DN_cspA_78nt 
GATGAGGAAAATAGGTATAAGTTTATAGATCTATCAGGAATAGATGTAGT
CCA 
1238 3' 1Kb UP_cspB_78nt 
AAACTTATACCTATTTTCCTCATCTTTAAAATCTGATAAATTTAAAAAACC
AA 
1239 5' 1Kb DN_cspB_78nt 
TCAGGATTTGGTTTTTTAAATTTATCAGATTTTAAAGATGAGGAAAATAG
GT 
1258 3' cspB_A _75aa_pRS114 TTTCATTCTCTAAGTCATTATA 
1259 3' cspB_A _102aa_pRS115 ACTTATATAAATTTCATTCGT 
1260 3' cspA _76aa_pRS116 TATTCCTGATAGATCTA 
1261 3' cspB_76aa_pRS117 CCTCATCTTTAAAATCTGAT 
1287 3' 1Kb UP CspA_150nt 
TACACCTAATGAATCACTTATCTTAAAAAAATCTATAAACTTATACCTATT
TTCCT 
1288 5' 1Kb DN CspA_150nt 
GATGAGGAAAATAGGTATAAGTTTATAGATTTTTTTAAGATAAGTGATTC
ATTAG 
1361 
5' YN4_SleC_1kB UP 
TTCGAGCTCGGTACCCGGGGATCCTCTAGAAGCTAAAAATACAGAGTAAA
TAATAC 
1362 3' SleC_SQRS Del_1Kb UP AGTATGTTCTCCTATGTCAAAAATCAACTCGAAAGAACGCTTACTTCTTG 
1363 5' SleC_SRQS del_1kB DN CTCCTAGAACAAGAAGTAAGCGTTCTTTCGAGTTGATTTTTGACATAG 
1364 
3' YN4_SleC_1Kb DN 
TGCCAAGCTTGCATGTCTGCAGGCCTCGAGATAATAAATAATAATTTAGA
TAA 
1365 3' SRQS del cspA ATTCCTGATTGTCTACT 
1376 5' SleC SRQS del GCGTTCTTTCTCAAGACAAAGT 
 
 
  
97 
 
 
CHAPTER V 
TERBIUM CHLORIDE INFLUENCES Clostridium difficile SPORE 
GERMINATION, LIKELY AS A CALCIUM SUBSTITUTE 
 
 In Chapter V, I found that terbium which is used while measuring germination by 
DPA release also influences C. difficile spore germination similar to calcium. I also found 
the TA-terbium phenotype can be stronger depending upon the media composition on 
which the C. difficile spores are generated.  
  
5.1 Introduction 
Patients treated with broad-spectrum antibiotics have a disrupted gut microbiome 
and, as a result, are vulnerable to C. difficile infection (CDI) due to the loss of the 
colonization resistance that is provided by the microbiota (131). Upon colonization of the 
intestinal tract, C. difficile vegetative cells elicit the symptoms of disease through the 
secretion of two toxins, TcdA (an enterotoxin) and TcdB (a cytotoxin) and their eventual 
endocytosis by the colonic epithelial cells (163). C. difficile-infected patients are 
commonly treated with other antibiotics, such as vancomycin or fidaxomicin, which 
relieve the primary symptoms of CDI by targeting the actively-growing, toxin-producing, 
vegetative forms (8). However, and importantly, these antibiotics also disrupt the gut 
microbiome and may result in recurring episodes of disease(164). 
Though the C. difficile vegetative cells are strictly anaerobic, they form 
metabolically dormant spores that are resistant to toxic chemicals, high temperature, 
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radiation and oxygen (34, 135, 165). As a result of this dormancy, the spores can survive 
outside the host in the aerobic environmental setting where the strictly anaerobic, 
vegetative form cannot. Structurally, endospores are composed of several, well-defined 
layers (166). The endospore core contains DNA, RNA, ribosomes and a large amount of 
dipicolinic acid (pyridine-2-, 6-dicarboxylic acid; DPA), chelated with calcium (CaDPA) 
that provides heat resistance (34, 167). The core is surrounded by an inner spore membrane 
composed of phospholipids, followed by a layer of germ-cell wall (which later becomes 
the cell wall of the vegetative cell during outgrowth). A thick layer of specialized 
peptidoglycan, cortex, surrounds the germ-cell wall and protects the spore core against 
osmolysis. The cortex is surrounded by the outer membrane derived from the mother cell, 
coat proteins and an exosporium layer (34, 135, 166, 168). When the environmental 
conditions become favorable, spores germinate and outgrow to the vegetative form (135, 
169, 170). 
C. difficile spore germination is initiated in response to the combinatorial actions 
of certain bile acids [e.g., taurocholic acid (TA)] and amino acids (e.g., glycine) (144, 171-
174). In prior work, the bile acid germinant receptor was identified as the germination-
specific, subtilisin-like, pseudoprotease, CspC (61). More recently, we found that a small 
mutation in the cspA coding region of cspBA resulted in spores that germinate in response 
to TA alone (without the requirement for an amino acid), suggesting that the CspA protein 
is the amino acid germinant receptor (Shrestha and Sorg, submitted (175)). 
In several endospore-forming bacteria, the abundance of the spore germinant 
receptors is significantly influenced by the medium used to generate the spores (176). C. 
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difficile spores are generally prepared in rich media at an optimal temperature and cell 
density for higher yields (51). A study by Hornstra et al., demonstrated that in Bacillus 
cereus ATCC 14579, the composition of the sporulation medium increased the 
transcription of the seven germinant receptors, and the nutrient-induced spore germination 
was significantly affected (177). Similar results were also observed in other spore-forming 
bacteria (e.g., B. subtilis) (176), however, no studies have been performed in C. difficile 
on how the medium used to generate spores influences the properties of spore germination; 
although there are studies that show that high spore yield can be obtained when C. difficile 
spores are produced in peptone rich medium, such as 70:30 or SMC (51, 72, 178-181). 
Here, we report that media composition influences the abundance of the C. difficile spore 
germinant receptors and find that spores prepared on peptone-rich medium can germinate 
in response to TA and terbium ions (which likely function as a calcium substitute). 
Because Tb3+ ions are often used to detect the presence of the dipicolinic acid that is 
released during the early events of spore germination (144, 174, 182-187), these findings 
could be useful for future analysis of C. difficile spore germination or for the germination 
of other bacteria that are influenced by calcium ions. 
 
5.2 Materials and methods 
5.2.1 Growth conditions 
C. difficile UK1 (ribotype 027) (61, 188, 189) and M68 (ribotype 078) (90, 144, 
189) strains were grown on either BHIS agar medium [Brain heart infusion (BHI) 
supplemented with 5 g / L yeast extract] or 70:30 agar medium [63 g / L Bacto peptone, 
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3.5 g / L protease peptone, 11.1 g / L BHI, 1.5 g/ L yeast extract, 1.06 g / L tris base and 
0.7 g / L ammonium sulfate (NH4SO4)] or SMC agar medium ( 90 g / L Bacto peptone, 5 
g / L protease peptone, 1 g / L NH4SO4 and 1.5 g / L tris base) or TYG agar medium [(30 
g / L Bacto typtone, 20 g / L yeast extract and 10 g / L glucose)] in an anaerobic 
environment (85% N2, 10% H2, and 5% CO2) (Model B, Coy Laboratories, Grass Lake, 
MI) at 37 °C. The BHIS, 70:30 and SMC agar media were supplemented with 1 g / L of 
L-cysteine while TYG agar medium was supplemented with 1 g / L thioglycolate. 
5.2.2 Spore purification 
C. difficile spores were purified as described previously (144, 174). Briefly, the C. 
difficile UK1 and C. difficile M68 strains were grown on either BHIS, 70:30, SMC or TYG 
agar medium as described above and allowed to grow for 4 days. Cells from each plate 
were scraped into 1 mL sterile water and incubated at 4 °C overnight. Next, the cells were 
washed five times with water to remove cell debris and combined into 2 mL total volume. 
The washed spores were layered on top of 8 mL of 50% sucrose and centrifuged at 4,000 
X g for 20 minutes. The spore pellets were separated from the supernatant, and the spores 
were washed five times with water to remove any sucrose and incubated at 4 °C until use. 
5.2.3 Germination of spores isolated from different media 
 The spores were characterized by measuring DPA release as well as changes to the 
optical density (OD600) during germination, as described previously (144, 184). Briefly, 
spores purified from various media were heat activated at 65 °C for 30 minutes and 
suspended in water at an OD600 = 50. In order to measure DPA release, the spores were 
added to final OD600 of 0.25 in 100 µL final volume of buffer (50 mM HEPES, 250 mM 
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NaCl, pH 7.5) supplemented with 250 µM Tb3+ and containing either 10 mM TA or 30 
mM glycine or both 10 mM TA and 30 mM glycine in a 96 well black plate. The DPA 
release was then measured for 2 hours at 37 °C using a SpectraMax M3 (Molecular 
Devices) plate reader with excitation at 270 nM and emission at 545 nm with a 420 nm 
cutoff. 
 In order to measure the germination by optical density, the spores were added to a 
final OD600 of 0.5 in HEPES buffer supplemented with 30 mM glycine alone or 10 mM 
TA alone or 10 mM TA and 30 mM glycine in 100 µL final volume with or without 250 
µM Tb3+ in 96 well clear plates. OD600 was monitored at 37 °C for 2 hrs. using the plate 
reader. 
5.2.4 Western blot 
Samples for SleC activation were prepared by treating UK1 and M68 spores with 
either 10 mM TA or 30 mM glycine or both 10 mM TA and 30 mM glycine with or without 
250 µM Tb3+ and incubated at 37 °C for 2 hours. Soluble protein samples were extracted 
by boiling the spores in NuPage buffer (Life Technologies) at 95 °C for 20 minutes and 
centrifuged at 20,000 x g for 10 minutes to separate supernatant from the spore pellet. 
Solubilized proteins were separated by SDS-PAGE and transferred onto a nitrocellulose 
membrane for SleC detection by western blot. 
In order to quantify amounts of SleC, CspB, and CspC proteins in spores prepared 
from different media, solubilized proteins were extracted by boiling 2 x 109 spores per mL 
in NuPAGE (Life Technologies) sample buffer at 95 °C for 20 minutes. Equal volume of 
spore extracts and recombinant CspB, CspC or SleC standard proteins were separated by 
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SDS-PAGE. Proteins were then transferred onto low-fluorescence polyvinylidene 
difluoride membrane (PVDF) at 30V for 16 hours. The membrane was then blocked in 
10% skimmed milk in TBS (Tris-buffered saline) and washed thrice with TBS containing 
0.1% (vol / vol) Tween-20 (TSBT) for 20 minutes each at room temperature. The 
membranes were then incubated with anti-CspB, anti-CspC or anti-SleC antibodies for 2 
hours and washed thrice with TSBT. For the secondary antibody, AlexaFlour 555-labeled 
donkey anti-rabbit antibody was used to label the membranes for 2 hours in the dark. The 
membranes were washed again thrice with TBST in the dark, and scanned with a GE 
Typhoon Scanner using Cy3 setting, an appropriate wavelength for the Alexa Flour 555 
fluorophore. The fluorescent bands were analyzed using ImageQuant TL 7.0 image 
analysis software. Intensity of the extracted protein in each blot was compared to the 
standard curve that was included on each blot. 
5.2.5 Calcium measurement 
Calcium concentrations in different media were measured using a Ca2+ detection 
assay kit (Abcam, ab102505). Standards for Ca2+ were prepared as advised in the kit. The 
Ca2+ concentration was then measured from BHI, BHIS, 70:30, SMC and TYG medium 
at OD575 in the plate reader. The OD575 values for the Ca
2+ measurement were then 
converted into µg / L. For the control, 23 mg / L CaCl2 suspended in water was used. 
5.2.6 Statistical analysis 
All germination assays were performed in triplicate and data points represent the 
average of three independent experiments. Calcium concentrations were measured in 
triplicate. Error bars represent the standard error of the mean. A one-way ANOVA with 
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Tukey’s multiple comparisons test was used to compare the quantified protein amounts. 
Each blot was loaded with five standard proteins and three spore samples for 
quantification of proteins. 
5.3 Results 
5.3.1 Tb3+ enhances the germination of C. difficile spores with TA 
Recent work by Kochan et al., on germination by C. difficile spores has shown that 
calcium plays a role as an enhancer of germination when added with TA (179). In several 
studies, terbium has been used to replace calcium, mostly to observe the calcium binding 
because terbium fluoresces at certain wavelengths and calcium does not (190, 191). One 
of the ways germination is observed is through the measurement of the DPA that is 
released from the spore core. Upon recognition of germinants by C. difficile spores, the 
cortex layer is degraded by the cortex lytic enzyme (SleC) and, subsequently, DPA is 
released from the core (192). In the presence of terbium ions, the released DPA can 
associate with terbium and the terbium-DPA complex can be detected in a FRET-like 
assay. 
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Figure 18. Comparison of germination by C. difficile UK1 spores in presence/absence 
of terbium. C. difficile UK1 spores were prepared from BHIS medium as described in the 
materials and methods. (A) CaDPA release from the purified spores was analyzed by 
suspending the spores in buffer supplemented with 250 µM TbCl3 and (●) 30 mM glycine, 
(■) 10 mM TA or (▲) 10 mM TA and 30 mM glycine. The extent of germination was 
also analyzed by determining OD600 over time. Germination by C. difficile spores was 
analyzed in the absence of TbCl3 (B) or in the presence of 250 µM TbCl3 (C). Data points 
represent the averages from three independent experiments and error bars represent the 
standard error of the mean. (D) Equal numbers of spores were incubated with or without 
250 µM TbCl3 in 30 mM glycine or 10 mM TA or 10 mM TA and 30 mM glycine for 2 
hours and soluble proteins were extracted with NuPAGE buffer and separated by SDS-
PAGE followed by immunoblotting with SleC- specific antisera. 
During some of my experiments analyzing the requirements of C. difficile spore 
germination, we found that, at times, wild type C. difficile spores would seemingly release 
DPA in response to TA alone. To investigate this phenomenon further, we measured DPA 
released from spores that were prepared on BHIS medium. We found that these spores 
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started to release DPA in response to TA alone after 1 hr 30 min incubation in these 
conditions (Figure 18A). However, when germination was measured by OD at 600 nm, in 
absence of terbium, the OD did not change with TA alone (Figure 18B). Surprisingly, 
when the germination was measured by OD in presence of terbium, the OD changed in 
response to TA alone (Figure 18C) – the germination rate was much faster when glycine 
was added as a co-germinant. To confirm that our observations were due to the initiation 
of spore germination and not just an artifact of the assay conditions, we tested the 
activation of SleC after two hours of incubation in the indicated germination condition. 
We found that in presence of terbium, SleC is activated when the spores were treated with 
TA alone, similar to the activation of SleC in response to both TA and glycine (Figure 
18D). These results suggest that terbium might be involved in germination of the spores, 
potentially similar to the response of C. difficile spores to calcium. 
5.3.2 The TA-terbium response increased when spores were prepared in peptone rich 
medium 
Many C. difficile strains do not efficiently form spores in liquid BHIS medium. 
Therefore, most studies produce spores on agar medium (e.g., BHIS, 70:30, or SMC) 
(51).To investigate if our observation that spores germinate in response to TA and Tb3+ 
was due to how spores were prepared (i.e., BHIS agar medium, on which our laboratory 
normally produces spores), we prepared spores on BHIS, 70:30, SMC or TYG agar 
medium and tested how Tb3+ influences germination of these spores. Interestingly, we 
found that the TA-terbium phenotype increased when spores were prepared in the peptone 
rich media, when compared to BHIS agar medium. In figure 19A, 19D, and 19G we 
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compared DPA release of wildtype C. difficile UK1 spores prepared from 70:30, TYG or 
SMC agar medium, respectively. We found that the influence of Tb3+ on C. difficile spore 
germination was greater in these media compared to BHIS-prepared spores (Figure 18A). 
Similar to what we observed for BHIS-prepared spores, none of these spores germinated, 
as measured by changes in OD600, in the absence of Tb
3+ (Figure, 19B, 19E, and 19H). 
However, when terbium was added with TA, the OD of the spore suspension dropped in 
response to TA and Tb3+ (Figure 19C, 19F and 19I). We also confirmed that the activation 
of SleC occurred in presence of TA and Tb3+ (Figure S11). These results strongly suggest 
that the medium used to prepare spores plays a role in the TA-terbium phenotype; the 
spores become more responsive to terbium when produced on a more peptone rich media 
(e.g., 70:30, SMC and TYG). 
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Figure 19. Comparison of germination by C. difficile UK1 spores prepared in 
different media. The germination phenotype of wild type C. difficile UK1 spores prepared 
from (A, B, C) 70:30 medium, (D, E, F) TYG medium or (G, H, I) SMC medium were 
analyzed as described in Figure 18 (●) 30 mM glycine, (■) 10 mM TA or (▲) 10 mM TA 
and 30 mM glycine. Data points represent the averages from three, independent 
experiments and error bars represent the standard error of the mean. 
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5.3.3 TA-terbium phenotype is found in a different C. difficile ribotype 
Next, we wanted to test if the TA-terbium phenotype is only true for the C. difficile 
UK1 strain or if it is observed in another ribotype. In our prior work on C. difficile spore 
germination, we used the C. difficile M68 strain (ribotype 078) to test the impact of 
muricholic acids and the effect of different amino acids on C. difficile spore germination 
(90, 144). Thus, we used this strain to investigate the impact of Tb3+ on germination by C. 
difficile spores. As for C. difficile UK1, we prepared C. difficile M68 spores in BHIS, 
70:30 or SMC agar medium (M68 strains did not form spores on TYG medium for 
unknown reasons) and measured DPA release (Figure 20A, 20D and 20G). The M68 strain 
also germinated in response to TA and Tb3+ and, similar to C. difficile UK1 spores, this 
phenotype was stronger for spores prepared from 70:30 and SMC compared to spores 
prepared from BHIS agar medium. Similarly, when we tested germination by OD, in the 
absence of terbium, spores did not germinate in response to TA alone (Figure 20B, 20E 
and 20H). However, the addition of Tb3+ to the germination solution resulted in 
germination (Figure 20F and 20I); BHIS prepared spores (Figure 20C) had a much milder 
response to TbCl3 addition than did 70:30- or SMC-prepared spores (Figure 20F and 20I). 
These observations were also confirmed, as for C. difficile UK1, by analyzing SleC 
activation (Figure S12). 
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Figure 20. Comparison of germination by C. difficile M68 spores prepared in 
different media. The germination phenotype of wild type C. difficile M68 spores prepared 
from (A, B, C) BHIS medium, (D, E, F) 70:30 medium and (G, H, I) SMC medium were 
analyzed as described in Figure 18 (●) 30 mM glycine, (■) 10 mM TA or (▲) 10 mM TA 
and 30 mM glycine. Data points represent the averages from three, independent 
experiments and error bars represent the standard error of the mean. 
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5.3.4 Medium composition influences the abundance of C. difficile spore germinant 
receptors but does not explain TA-Tb3+ phenotype 
In B. subtilis, it was shown that spores prepared on different media resulted in changes to 
the amount of Ger proteins found within the spores (176). We hypothesized that spores 
prepared in peptone rich media may have increased amounts of the germinosome proteins 
(i.e., CspB, CspC or SleC) which could influence the sensitivity of spores to terbium. To 
test this hypothesis, we quantified the amount of CspB, CspC and SleC proteins purified 
from the different media mentioned above using a previously described technique (due to 
the quality of our CspA antibody, we could not quantify the abundance of CspA in the 
spores). We found that there was not a significant increase in SleC levels for C. difficile 
UK1 or C. difficile M68 spores that were purified from different media (Figure 21A and 
21B, respectively). We observed an increase in CspB protein purified from 70:30, TYG 
or SMC media compared to BHIS-prepared medium for spores derived from the C. 
difficile UK1 strain (Figure 21C). However, for C. difficile M68, spores prepared from 
BHIS contained a larger amount of CspB than did spores prepared on 70:30 or SMC media 
(Figure 21D). We also observed small differences in abundance of CspC in both the strains 
purified from different media (Figure 21E, 21F). But, because CspC abundance in C. 
difficile UK1 SMC-prepared spores was lower than in TYG and C. difficile M68 SMC-
prepared spores was more abundant the abundance of CspC is not likely to contribute to 
the observed phenotypes. These results suggest that producing C. difficile spores on 
different media can influence the abundance of some spore proteins. However, we did not 
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observe a correlation between medium and the Tb3+ phenotype observed in Figures 18, 19 
and 20. 
Figure 21. Quantifying the abundance of CspB, CspC and SleC in C. difficile spores. 
2 x 109 spores purified from C. difficile UK1 strain (A, C, E) or the C. difficile M68 strain 
(B, D, F) that were generated in BHIS medium, 70:30 medium, TYG medium or SMC 
medium. The proteins were extracted with NuPAGE buffer and samples were separated 
by SDS-PAGE, transferred to low fluorescence PVDF membranes and blotted with 
antisera specific to the indicated proteins. Quantified proteins are expressed as molecules 
/ spore and are represented in a bar graph form (A, B) SleC, (C, D) CspB and (E, F) CspC. 
The data presented represent the averages from three independent experiments and error 
bars represent the standard error of the mean. Statistical significance was determined using 
a one-way ANOVA with Tukey’s multiple comparisons test (* p < 0.05; *** p < 0.001). 
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5.3.5 The calcium concentrations are similar in different media 
 In several studies, terbium has been used to substitute calcium. Previous studies 
by Kochan et al. have also shown that calcium is involved in enhancing germination by 
C. difficile spores in the presence of germinants (TA and glycine) (178, 179). We 
hypothesized that TA-terbium is functioning similar to TA-calcium and that a difference 
in the calcium concentration in the media used to prepare spores might contribute to spores 
being sensitive to calcium or terbium in these germination assays. In order to test this 
hypothesis, we used a colorimetric assay to detect calcium concentration in various media. 
However, we observed no significant difference in the calcium concentration in BHIS, 
70:30, SMC or TYG media (Figure 22). These results suggest that an unidentified factor 
contributes to the sensitivity to terbium during C. difficile spore germination and that to 
detect the release of DPA from germination of C. difficile spores, the concentration of 
terbium should be optimized so as not to influence germination during the assay 
conditions. 
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Figure 22. Detection of calcium concentration in different media types. Bar graph 
representing the calcium concentration in µg / L from BHI, BHIS, 70:30, TYG and SMC 
media. 23 mg/mL of calcium chloride dissolved in water is used as a control. 
 
 
 
5.4 Discussion 
Growth media plays a significant role in formation of spores (51, 176, 177). A 
common medium used for the growth of C. difficile vegetative cells is BHIS agar medium; 
however, C. difficile spores are frequently produced in / on 70:30 or SMC medium because 
of the improved spore yield in these media (51, 72, 178-181). Importantly, the different 
composition of sporulation media can impact the germination phenotype of the spores. 
For example, Ramirez-Peralta et al., showed for B. subtilis spores the medium 
composition had a significant effect on the rate of spore germination (176). The rate of 
germination of B. subtilis spores prepared from nutrient-rich, liquid medium was 
significantly higher compared to nutrient-poor, liquid medium. Similarly, we found that 
germination of spores prepared under different sporulation conditions (media) resulted in 
significant differences in germination. Specifically, when we prepared spores from the 
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BHIS medium, at the end of 2 hours germination we observed slight increase in DPA 
release in presence of TA alone (Figure 18A); the release of DPA corresponds to 
germination. Oddly, when the OD assay was used to measure the germination, there was 
no germination in TA alone (Figure 1B). The difference between the assays is the addition 
of terbium to monitor DPA release. When terbium was added in the OD assay, we 
observed that, similar to DPA increase in TA alone, germination was observed with OD 
within 2 hours suggesting that it was terbium, along with TA, that induced the germination 
of the spores. Although C. difficile is known to germinate in the presence of bile acids 
(e.g., TA) and amino acids (e.g., glycine), calcium has been identified as an important 
contributor to spore germination, though its role remains undefined (134, 178, 179). It is 
not clear whether calcium functions as a bona fide spore co-germinant, a co-factor for a 
process essential for spore germination and / or as an enhancer for amino acids. But, 
removal of calcium by chelation prevents spore germination, indicating that calcium is 
essential for C. difficile spore germination, and addition of calcium increases the 
sensitivity of spores to germinants (179). 
We found that the TA-terbium germination phenotype increased when spores were 
prepared from peptone rich medium, such as 70:30, SMC or TYG, and compared to BHIS-
prepared spores. As shown in Figure 19, when spores were produced from 70:30, TYG or 
SMC medium, the spores germinated in response to TA-terbium within 1 hour. The TA-
terbium phenotype was stronger in spores prepared from SMC medium followed by TYG, 
70:30 then BHIS medium. These results were also true for the C. difficile M68 strain 
(Figure 20). We found that in wildtype C. difficile UK1 spores, CspB abundance was 
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significantly increased in SMC, 70:30 or TYG medium compared to BHIS medium, but 
this was not true for C. difficile M68 spores. Unfortunately, we could not analyze the 
abundance of CspA in this study. It is possible that CspA abundance correlates with the 
observed phenotype, but we cannot test this directly. 
We hypothesized that the calcium concentration in BHIS medium was greater, thus 
reducing the effect of Tb3+ on germination (i.e., the spore would already be saturated with 
Ca2+ and be less influenced by Tb3+). However, there were no significant differences in 
the calcium concentration in different media (Figure 22). Although the mechanism for the 
increase in terbium sensitivity in spores prepared in different media is not known, there 
could be various other media components that might relate to the terbium sensitivity. 
However, we feel that it is important to report the impact of Tb3+ on C. difficile spore 
germination because analysis of DPA release is a common screening technique in spore 
germination studies. An increase in sensitivity to terbium may be confused with a bona 
fide germination phenotype and it is important to confirm the germination phenotype with 
different assays, such as the OD assay or SleC activation during germination. Finally, we 
recommend that the Tb3+ concentration used for each C. difficile strain be titered 
accordingly so as not to influence the germination process. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
  Although, germination of Clostridium difficile spores is a critical step in C. difficile 
pathogenesis, the mechanism by which C. difficile spores germinate is not yet fully 
understood. The C. difficile spore germination pathway differs from that of other well-
studied model organisms, such as B. subtilis or C. perfingens. Even though the underlying 
biology of a novel prosess warrants investigation, it is important for us to understand the 
C. difficile spore germination pathway in order to develop new theraputics that target the 
germination related proteins. These future anti - C. difficile compounds would not target 
other members of the colonic microbiota, and would ensure prevention of recurrence, 
which is a common problem with current CDI treatment options. Below, I will summarize 
my findings on the mechanisms of C. difficile spore germination in response to amino 
acids, along with the effect of the spore specific alanine racemase on germination, and 
propose potential future avenues for study. 
6.1 Role of alanine racemase in C. difficile spore germination 
Prior work by Fimlaid et. al., showed that the Alr2 alanine racemase is one of the 
most highly expressed genes during sporulation (71). However a mutation in alr2 does not 
affect C. difficile spore germination when measured in rich medium (71). To further 
investigate the role of the Alr2 in germination, I engineered an alr2 mutation (TargeTron 
insertion mutation) and tested the germination phenotype in buffer supplemented with a 
fixed concentration of taurocholic acid (TA) and varying concentrations of either L-
alanine or D-alanine . Interestingly, I found that the alr2 mutation affected C. difficile 
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spore germination differently in response to L-alanine versus D-alanine. The results, and 
a model to explain these reults, are shown in Figure 23. In the spores lacking Alr2, L-
alanine was more efficient germinant than D-alanine. The EC50 for L-alanine was 2.7 mM, 
while the EC50 for D-alanine was almost 10-fold higher at 24.2 mM. In the wildtype C. 
difficile spore, where Alr2 can interconvert, D-alanine and L-alanine, the EC50 for D-
alanine decreased to 11.5 mM, and the EC50
 for L-alanine was increased to 5.5 mM. These 
results suggest that the germination that was observed in response to D-alanine, was due 
to a response to both D-alanine and L-alanine (that was converted by Alr2). In addition, 
germination of WT spores in the presence of the L-alanine and TA, was effiecent (EC50 
5.5 mM) than the germination in response to D-alanine (Figure 23B). My results suggest 
that the germination of WT spores in response to L-alanine is due to both L-alanine as 
well as D-alanine. This is perhaps why there was no effect in germination in alr2 mutants 
when observed in the rich medium (where all amino acid signals are available, especially 
glycine). 
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Figure 23. Proposed role of alanine racemase Alr2 during C. difficile spore 
germination. The Alr2 racemase is indicated by the blue square, the purple and blue ovals 
represent D-alanine and L-alanine respectively. The EC50 is the concentration of D-alanine 
or L-alanie where the rate of germination is 50 % the maximum rate. All germination 
assays were performed with 10 mM TA and were performed at 37 °C A) In alr2 mutants, 
the alanine racemase does not convert L or D form of alanine, germination occurs only 
with in presence of D-alanine (Left) or L-alanine (Right). The EC50 values for the 
germination with both L-alanine and D-alanaine in absence of Alr2 is reported. B) In the 
WT, the alanine racemase (requires PLP as co-factor) is active, germination in presence 
of D-alanine also has L-alanine converted by Alr2 and vice-versa. The EC50 values in 
response to L-alanine and D-alanine in presence of active Alr2 is reported. The EC50 
values are specific to UK1 strains, and might be different for other C. difficile strains.  
 
 
6.2  Hierarchy of amino acid co-germinant recognition by C. difficile spores 
While studying D-alanine as a co-germinant, I found that the temperature at which 
the germination assays were conducted played a significant role in the germination of C. 
difficile spores. At room temperature, D-alanine did not contribute to germination, but at 
37 °C D-alanine was recognized as a co-germinant even though the efficiency of 
germination was lower compaired to that of L-alanine. This is a first time I showed that 
along with D-alanine, other D-forms of amino acids such D-serine and D-lysine, could 
A B 
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contribute to C. difficile spore germination when tested at 37 °C (but not at 25 °C). Based 
on the EC50 value calculated at 37 °C I ranked the soluble amino acids as co-germinants 
(Table 4 and Table 5). My results suggest that the putative amino acid germinant receptor 
is very promiscuous. 
6.3 Updated model of C. difficile spore germination 
  When I made SRQS deletion mutation in cspA of C. difficile, I observed that the 
spores no longer required amino acids for germination and the spores germinated in 
response to TA alone. Based on my results, I hypothesized that CspA is the amino acid 
germinant receptor, and proposed a model for the role of amino acids during C. difficile 
spore germination (Figure 19). In my previous working model I proposed that CspC, 
CspB, CspA and proSleC were all forming a germinosome complex, and were localized 
in the spore cortex (Figure 3). In my current, updated model, I propose that only CspC, 
CspB and CspA but not proSleC are in a complex. In this complex, the protease activity 
of CspB is inhibited by CspA and CspC. In the presence of germinants, the bile acid 
germinant receptor, CspC, binds to TA and the amino acid receptor germinant, CspA binds 
to glycine and both CspC and CspA fall off the complex freeing the CspB protease. Free 
CspB is then able to convert proSleC to SleC which then degrades the cortex layer and 
leads to the release of DPA. Based on the EC50 values of different amino acid during spore 
germination, I hypothesize that CspA can recognize different amino acids with varying 
efficiencies. Inhibition of germination by chenodeoxychoic acid (CDCA) could be 
explained if the presence of CDCA prevents CspC from binding TA (62) and the presence 
amino acid alone cannot free CspB from the complex. 
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Figure 24. Updated model for C. difficile spore germination pathway. CspB activity 
is inhibited by CspC and CspA. Once CspC binds TA and CspA binds amino acids such 
as glycine, both proteins fall off the complex and CspB becomes free to cleave proSleC 
into active SleC. Activate SleC then degrades the cortex allowing spores to release DPA 
from the core in exchange for water molecules. The CspC protein is unable to leave the 
complex when CDCA is present and CspB remains inactive. 
 
 
6.4 Future directions 
 Apart from the alanine racemase, other amino acid racemases present in the spore 
(e.g., proline racemase) could also contribute to the germination. Whether the other amino 
acid racemases also play a role in C. difficile spore germination need to be determined. 
  One way to test the model shown in Figure 24, is by purified CspA, CspC, and 
CspB proteins in E. coli and determine if they form a complex in vitro by using functional 
assay looking for cleavage of proSleC. If we can sucessfully show that they form a 
complex, we can also test if the complex is altered by TA, glycine or both TA and glycine. 
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Another way to test my proposed model is to pull down the CspC and CspA proteins from 
the spore and identify co-precipitated protein(s). 
I found that the processing of CspBA by YabG is critical for the activity of CspA 
in the complex. To test if the YabG protease directly processes CspBA and preproSleC, 
we could recombinantly express and purify YabG, full length CspBA, and preproSleC 
protein from E.coli. Then, we could mix CspBA or preproSleC with YabG. Under this 
condition, if we observe processing of CspBA or preproSleC, we would conclude that 
YabG directly processes CspBA into CspB and CspA and preproSleC into proSleC. If we 
do not observe the processing of CspBA or preproSleC then that would suggest that there 
might be another protein that is required in addition to YabG for the processing of these 
proteins. 
If we find that YabG directly processes CspBA and preproSleC in the spore, we 
could then identify the YabG processing site in CspBA or preproSleC. For this experiment 
we would sequence the YabG-processed CspA or proSleC forms using Edman sequencing 
and observe if both of these proteins have similar target sequence. We could then use the 
identified target sequence(s) to find other protein sequences in the C. difficile spore that 
might be targeted by YabG. 
Another way to identify target proteins of the YabG protease is to run both YabG 
mutant spore extract and WT spore extract and separate the proteins using SDS-PAGE. 
By identifying the differences in the two spore extracts, we can cut the gel fragments and 
identify the sequence using mass spectometry. The results might give us possible target 
proteins of YabG. 
  
122 
 
 
Finally, to show if caclium works similarly to glycine during germination or works 
through a separate pathway similar to what is seen in most Bacillus species, we can test if 
germination is affected in our cspA mutant spores. Since, calcium can also be affecting the 
activity of CspB or SleC in the spore, when we purify recombinant CspB and proSleC we 
can test the effect of calcium and see if it can bypass the requirement of both TA and 
glycine in vitro and CapB can cleave proSleC to SleC. 
Identifying the amino acid receptor was very important for our understanding of 
the C. difficile spore germination pathway. Future work could develop new therapeutics 
that only target these germinant receptors (CspC and CspA) to prevent the in vivo 
germination of C. difficile spores while having little impact on the rest of the colonic 
microbiome. 
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APPENDIX A SUPPLEMENTAL FIGURES 
 
 
Figure S1. Germination by C. difficile spores in defined medium at 25 °C. Purified 
spores from (A) wildtype C. difficile UK1 or (B) C. difficile RS07 (alr2::ermB) or (C) C. 
difficile RS07 pRS89 (palr2) were suspended germination buffer supplemented with TA 
alone (●), or supplemented with glycine (■) or L-alanine (▲) or D-alanine (▼). CaDPA 
release from the germinating spores was monitored at 25 °C as an increase in Tb3+ 
fluorescence over time. Data points represent the average from three independent 
experiments and error bars represent the standard deviation of the mean. 
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Figure S2. Purity of recombinantly expressed Alr2. Ni-affinity-purified Alr2 was 
concentrated and separated on a Sephedex G200 size exclusion column. The peak at ~15 
minutes was collected and is Alr2. 
 
 
Figure S3. Purity of L / D alanine and serine used for germination, conversion and 
ITC. (A) L-alanine, (B) D-alanine, (C) L-serine, or (D) D-serine were labeled with FDAA 
and separated by HPLC. The amino acids used were >98 % pure and there is minimal 
detection of the opposite enantiomer in the labeling and HPLC analysis. 
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Figure S4. L / D conversion of alanine and serine during ITC. After completion of the 
ITC binding for (A) L-alanine or (B) D-alanine or (C) L-serine or (D) D-serine, the 
samples in the ITC cell were labeled with FDAA as described in the material and methods. 
The reacted samples were separated by HPLC. The HPLC retention times of each amino 
acid were determined using labeled amino acid standards. 
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Figure S5. Full data set of the germination plots in Figure 10 The germination 
phenotype of wild type C. difficile UK1 and mutant spores were screened by measuring 
CaDPA release in presence of (●) 30 mM glycine, (■) 10 mM TA or (▲) 10 mM TA and 
30 mM glycine. 
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Figure S6. C. difficile yabG::ermB spores do not respond to L-alanine. Spores purified 
from (A) C. difficile R20291 or (B) C. difficile RS08 strains were suspended in buffer 
supplemented with 250 µM Tb3+ and (●) 10 mM TA or (□) 10 mM TA and 30 mM L-
alanine and CaDPA release was monitored. 
 
 
 
 
 
Figure S7. CaDPA release for C. difficile CRG2359 pyrE+ (RS19) and cspBAΔ548-560 
(RS18). CaDPA release from spores purified from C. difficile CRG2359 with restored 
pyrE and RS18 (cspBAΔ548-560; restored pyrE) strains was analyzed by suspending the 
spores in buffer supplemented with 250 µM Tb3+ and (●) 30 mM glycine or (■) 10 mM 
TA or (▲) 10 mM TA and 30 mM glycine. 
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Figure S8. Monitoring CaDPA release from spores with defined deletions in cspBA. 
CaDPA release during spore germination of the indicated strain was monitored by 
suspending spores in buffer supplemented with Tb
3+ and (●) 30 mM glycine or (■) 10 mM 
TA or (▲) 10 mM TA and 30 mM glycine. (A) CRG2359, (B) RS20 (cspBAΔ522-548), (C) 
RS21 (cspBAΔ560-586), (D) RS23 (cspBAΔ542-567), (E) RS24 (cspBAΔ537-571) and (F) RS27 
(cspBAΔ560-610). Data points represent the averages from three, independent experiments 
and error bars represent the standard error of the mean. 
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Figure S9. Comparing germination and western blots for spore purified from wild 
type and RS26. (A, B) Spores purified from C. difficile RS19 (CRG2359 with restored 
pyrE) and RS26 (cspBAΔ560-586; restored pyrE) strains were suspended in buffer 
supplemented with (●) 30 mM glycine or (■) 10 mM TA or (▲) 10 mM TA and 30 mM 
glycine and OD600 was monitored over time. (C, D) CaDPA release from the indicated 
strains was determined as in A & B with buffer also supplemented with 250 µM Tb3+. (E) 
The activation of SleC from spores purified from R20291, RS19 and RS26 in presence of 
buffered 30 mM glycine or 10 mM TA or both 10 mM TA and 30 mM glycine was 
determined after incubation for 2 hours at 37 °C. (F) Equal numbers of spores derived 
from R20291, RS19 or RS26 were extracted, separated by SDS-PAGE and transferred to 
PVDF membranes for immunoblotting of CspB, CspA and CspC (* full length CspBA 
form, ** alternatively processed CspA). 
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Figure S10. CaDPA release for SRQS deletion mutants. CaDPA release during spore 
germination of the indicated strain was monitored by suspending spores in buffer 
supplemented with Tb3+ and (●) 30 mM glycine or (■) 10 mM TA or (▲) 10 mM TA and 
30 mM glycine. (A) RS29 (cspAΔSRQS), (B) RS30 (sleCΔSRQS), (C) RS31 (cspAΔSRQS; 
sleCΔSRQS). Data points represent the averages from three, independent experiments and 
error bars represent the standard error of the mean. 
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Figure S11. SleC activation with/without terbium for UK1 spores. Equal numbers of 
C. difficile UK1 spores prepared in with 70:30, SMC or TYG medium were incubated 
with or without 250 µM terbium in 30 mM glycine or 10 mM TA or 10 mM TA and 30 
mM glycine for 2 hours and soluble proteins were extracted with NuPAGE buffer and 
separated by SDS-PAGE followed by immunoblotting with SleC antisera to observe SleC 
activation. 
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Figure S12. SleC activation with/without terbium for M68 spores. Equal numbers of 
C. difficile M68 spores prepared in with BHIS, 70:30 or SMC medium were incubated 
with or without 250 µM terbium in 30 mM glycine or 10 mM TA or 10 mM TA and 30 
mM glycine for 2 hours and soluble proteins were extracted with NuPAGE buffer and 
separated by SDS-PAGE followed by immunoblotting with SleC antisera to observe SleC. 
